<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">89221</article-id><article-id pub-id-type="doi">10.7554/eLife.89221</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.89221.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>PAK3 downregulation induces cognitive impairment following cranial irradiation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-318606"><name><surname>Lee</surname><given-names>Haksoo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3778-8300</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-243248"><name><surname>Kang</surname><given-names>Hyunkoo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241653"><name><surname>Moon</surname><given-names>Changjong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2451-0374</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-101117"><name><surname>Youn</surname><given-names>BuHyun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8010-519X</contrib-id><email>bhyoun72@pusan.ac.kr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an57a31</institution-id><institution>Department of Integrated Biological Science, Pusan National University</institution></institution-wrap><addr-line><named-content content-type="city">Busan</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05kzjxq56</institution-id><institution>Department of Veterinary Anatomy and Animal Behavior, College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University</institution></institution-wrap><addr-line><named-content content-type="city">Gwangju</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an57a31</institution-id><institution>Department of Biological Sciences, Pusan National University</institution></institution-wrap><addr-line><named-content content-type="city">Busan</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an57a31</institution-id><institution>Nuclear Science Research Institute, Pusan National University</institution></institution-wrap><addr-line><named-content content-type="city">Busan</named-content></addr-line><country>Republic of Korea</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ye</surname><given-names>Keqiang</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>Chinese Academy of Sciences</institution></institution-wrap><country>China</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Nelson</surname><given-names>Sacha B</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05abbep66</institution-id><institution>Brandeis University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>22</day><month>12</month><year>2023</year></pub-date><volume>12</volume><elocation-id>RP89221</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-06-15"><day>15</day><month>06</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-07-01"><day>01</day><month>07</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.06.30.547296"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-09-12"><day>12</day><month>09</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89221.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-11-30"><day>30</day><month>11</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89221.2"/></event></pub-history><permissions><copyright-statement>© 2023, Lee et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Lee et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-89221-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-89221-figures-v1.pdf"/><abstract><p>Cranial irradiation is used for prophylactic brain radiotherapy as well as the treatment of primary brain tumors. Despite its high efficiency, it often induces unexpected side effects, including cognitive dysfunction. Herein, we observed that mice exposed to cranial irradiation exhibited cognitive dysfunction, including altered spontaneous behavior, decreased spatial memory, and reduced novel object recognition. Analysis of the actin cytoskeleton revealed that ionizing radiation (IR) disrupted the filamentous/globular actin (F/G-actin) ratio and downregulated the actin turnover signaling pathway p21-activated kinase 3 (PAK3)-LIM kinase 1 (LIMK1)-cofilin. Furthermore, we found that IR could upregulate microRNA-206–3 p (miR-206–3 p) targeting PAK3. As the inhibition of miR-206–3 p through antagonist (antagomiR), IR-induced disruption of PAK3 signaling is restored. In addition, intranasal administration of antagomiR-206–3 p recovered IR-induced cognitive impairment in mice. Our results suggest that cranial irradiation-induced cognitive impairment could be ameliorated by regulating PAK3 through antagomiR-206–3 p, thereby affording a promising strategy for protecting cognitive function during cranial irradiation, and promoting quality of life in patients with radiation therapy.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cranial radiation</kwd><kwd>cognitive impairment</kwd><kwd>dendritic spine</kwd><kwd>intranasal administration</kwd><kwd>microRNA</kwd><kwd>p21-activated kinase 3</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002543</institution-id><institution>Pusan National University</institution></institution-wrap></funding-source><award-id>2-Year Research Grant</award-id><principal-award-recipient><name><surname>Youn</surname><given-names>BuHyun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>p21-activated kinase 3 (PAK3) is a factor related to radiation-induced cognitive decline, and it has been found that regulating it leads to the recovery of cognitive decline induced by radiation.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Radiotherapy is an important component of cancer treatment, which utilizes high-energy radiation to damage the DNA of cancer cells and prevent their growth and division (<xref ref-type="bibr" rid="bib8">Brown et al., 2018</xref>; <xref ref-type="bibr" rid="bib59">Owonikoko et al., 2014</xref>). Over the years, radiotherapy has undergone significant developments to improve its efficacy and minimize its side effects. Nevertheless, some adverse effects of radiotherapy have been reported, including cognitive impairment (<xref ref-type="bibr" rid="bib34">Houillier et al., 2019</xref>; <xref ref-type="bibr" rid="bib46">Krull et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Rapp et al., 2015</xref>; <xref ref-type="bibr" rid="bib70">Shah et al., 2015</xref>). One type of radiotherapy that has been associated with such adverse effects is prophylactic cranial irradiation (PCI), which is used to prevent the spread of cancer to the brain and is commonly administered to patients with certain types of cancer, such as small-cell lung cancer and acute lymphoblastic leukemia, who are at high risk of developing brain metastasis (<xref ref-type="bibr" rid="bib13">Conklin et al., 2012</xref>; <xref ref-type="bibr" rid="bib84">Xue et al., 2022</xref>). Notably, in the case of small-cell lung cancer, the cumulative risk of brain metastasis within 1 year was 14.6% in the PCI group and 40.4% in the non-PCI group. Accordingly, the 1 year survival rate was 27.1% in the PCI group and 13.3% in the non-PCI group (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> number, NCT00016211, <xref ref-type="bibr" rid="bib73">Slotman et al., 2007</xref>). However, it has been reported that the side effects of PCI inevitably affect 50–90% of long-term survivors with permanent and substantial cognitive impairment (<xref ref-type="bibr" rid="bib26">Greene-Schloesser et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Makale et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Rosi et al., 2008</xref>; <xref ref-type="bibr" rid="bib87">Zhang et al., 2018</xref>). The survivors treated with whole-brain irradiation exhibit severe impairment in memory (54.9%), processing speed (66.3%), and executive function (68.3%) (<xref ref-type="bibr" rid="bib7">Brinkman et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Krull et al., 2013</xref>). Moreover, the mechanisms underlying PCI-induced side effects remain poorly understood, and no treatment is currently available to address these adverse effects. Understanding the adverse effects associated with PCI is critical for developing strategies to minimize its impact on the cognitive function of cancer survivors.</p><p>Cognition is a complex mental process that involves the acquisition, processing, and application of knowledge (<xref ref-type="bibr" rid="bib28">Harvey, 2019</xref>; <xref ref-type="bibr" rid="bib38">Jessen et al., 2020</xref>). The frontal cortex and hippocampus are two critical regions of the brain that play a key role in cognition, including memory, attention, and decision-making (<xref ref-type="bibr" rid="bib11">Christensen et al., 2022</xref>; <xref ref-type="bibr" rid="bib32">Hogeveen et al., 2022</xref>; <xref ref-type="bibr" rid="bib61">Price and Duman, 2020</xref>; <xref ref-type="bibr" rid="bib69">Sakimoto et al., 2021</xref>). Cognitive impairment is a common feature of many psychiatric diseases, such as schizophrenia (<xref ref-type="bibr" rid="bib25">Gebreegziabhere et al., 2022</xref>; <xref ref-type="bibr" rid="bib37">Jauhar et al., 2022</xref>) and major depressive disorder (<xref ref-type="bibr" rid="bib19">Douglas et al., 2018</xref>; <xref ref-type="bibr" rid="bib81">Wen et al., 2022</xref>), and can significantly impact an individual’s quality of life. Despite the development of numerous therapies for psychiatric diseases, the limitations of the present cure have resulted in cognitive impairment remaining a persistent and unmet need in treating these conditions. Therefore, a deeper understanding of the underlying mechanisms of cognitive impairment is needed to develop more effective treatments and improve patients' quality of life suffering from these disorders.</p><p>Cognition is closely associated with dendritic spine morphology, which plays a key role in synaptic plasticity in the frontal cortex and hippocampus (<xref ref-type="bibr" rid="bib17">Delevich et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Lamprecht, 2021</xref>; <xref ref-type="bibr" rid="bib85">Yang et al., 2021</xref>). Dendritic spines are small protrusions that extend from the dendrites of neurons and play a critical role in synaptic plasticity, which is the ability of synapses (the junctions between neurons) to change strength and structure in response to experience (<xref ref-type="bibr" rid="bib5">Berry and Nedivi, 2017</xref>). Synaptic plasticity is believed to underlie learning and memory processes. The morphology of dendritic spines, which includes their shape, size, and density, is closely linked to synaptic plasticity and can influence cognitive function (<xref ref-type="bibr" rid="bib35">Huang et al., 2021</xref>; <xref ref-type="bibr" rid="bib58">Nakahata and Yasuda, 2018</xref>). For example, a higher density of dendritic spines in the frontal cortex has been associated with better cognitive function (<xref ref-type="bibr" rid="bib15">Counts et al., 2006</xref>; <xref ref-type="bibr" rid="bib17">Delevich et al., 2020</xref>), while a decrease in dendritic spine density in the hippocampus has been linked to memory impairment (<xref ref-type="bibr" rid="bib6">Bosch et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Kandimalla et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Szatmari et al., 2021</xref>). In neurons, the dendritic spine morphology is closely related to the balance between two forms of the cytoskeletal protein actin: filamentous actin (F-actin) and globular actin (G-actin) (<xref ref-type="bibr" rid="bib31">Hlushchenko et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Lei et al., 2016</xref>). F-actin is a rigid, filament-like structure that provides the structural stability required for dendritic spine maturation and synaptic function. G-actin is a monomeric form of actin that serves as the building block for F-actin and is critical for actin dynamics and the formation of new dendritic spines. An appropriate balance between F-actin and G-actin is essential for maintaining dendritic spine structure and function (<xref ref-type="bibr" rid="bib31">Hlushchenko et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Lei et al., 2016</xref>). Disruptions in this balance have been linked to cognitive dysfunction in various neurological and psychiatric disorders.</p><p>p21-activated kinase 3 (PAK3) is a serine/threonine kinase that plays a critical role in the regulation of dendritic spine morphology and synaptic plasticity (<xref ref-type="bibr" rid="bib12">Combeau et al., 2012</xref>; <xref ref-type="bibr" rid="bib78">Thévenot et al., 2011</xref>). PAK proteins function as Rac1 and Cdc42-specific effector molecules that mediate cytoskeletal remodeling by regulating LIM kinase (LIMK), oncoprotein 18 (OP18), and tubulin folding cofactor b (TBCB) (<xref ref-type="bibr" rid="bib56">Molli et al., 2009</xref>). PAK3 is highly expressed in the brain, particularly in postmitotic neurons of the cerebral cortex and the hippocampus, where it shows a diffuse distribution throughout the soma and proximal dendrites. PAK3-deficient mice exhibit defects in the morphology of dendritic spines, which lead to impairments in synaptic plasticity and cognitive function (<xref ref-type="bibr" rid="bib54">Meng et al., 2005</xref>). Several studies have reported that PAK3 is implicated in cognitive impairment in various neurological and psychiatric disorders, including schizophrenia and Alzheimer’s disease (AD) (<xref ref-type="bibr" rid="bib48">Lauterborn et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Morrow et al., 2008</xref>). However, the mechanism underlying PAK3-associated cognitive impairment has not yet been fully understood.</p><p>In this study, we investigated the impact of cranial irradiation on cognitive function and its underlying mechanisms. Our results demonstrate that IR reduced the level of PAK3, leading to the downregulation of PAK3-LIMK1-cofilin signaling, which correlates with the maturation of dendritic spines. We identified that microRNA-206–3 p (miR-206–3 p) regulates PAK3 and that its antagonist, antagomiR-206–3 p, restores PAK3 levels and cognitive function in irradiated mouse models. Our study provides valuable insights into the impact of cranial irradiation on the brain and its potential mechanisms, and a promising strategy to prevent PCI-induced cognitive dysfunction.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Cranial irradiation induces cognitive impairment in mice</title><p>Given that cranial irradiation is known to induce cognitive impairment (<xref ref-type="bibr" rid="bib18">Ding et al., 2022</xref>; <xref ref-type="bibr" rid="bib46">Krull et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">Makale et al., 2017</xref>), we first evaluated whether cranial irradiation impaired cognitive function in mice. To assess the effect of IR on cognitive function, we exposed mice to IR. Subsequently, we performed behavioral tests following the overall schedule (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). A total dose of 60 Gy in 30 fractions is typically delivered to the brain in patients with PCI (<xref ref-type="bibr" rid="bib76">Suwinski, 2021</xref>; <xref ref-type="bibr" rid="bib80">Wegner et al., 2019</xref>), and previous studies reported that a total dose of 10 Gy caused impaired neurogenesis and cognitive behavior in mice (<xref ref-type="bibr" rid="bib60">Pazzaglia et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Raber et al., 2004</xref>). In this regard, mice were irradiated with five fractions of 2 Gy administered to the cranial region (<xref ref-type="bibr" rid="bib9">Ceyzériat et al., 2021</xref>; <xref ref-type="bibr" rid="bib82">Wilson et al., 2020</xref>). Individual behavioral tests, such as the open field test (OPF), Y-maze, and novel object recognition test (NOR), were performed from days 3–8 post-IR. In mice treated with IR, spontaneous alteration and time in the novel arm were significantly reduced by 66.67% and 58.14%, respectively (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). The time spent with objects did not differ between familiar and novel objects in IR-treated mice (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Our previous study has shown that IR can induce depression-like behavior (<xref ref-type="bibr" rid="bib43">Kim et al., 2022</xref>). IR-treated mice exhibited reduced time in the center of the OPF, thereby indicating depressive-like behavior (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Based on the findings in the OPF, IR partially induced depression-like behavior, but the total distance traveled did not differ. These results indicate that IR could impair cognitive function and that depressive-like behavior does not impact overall moving behavior.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Cranial irradiation affects cognitive function and the maturation of dendritic spine.</title><p>(<bold>A</bold>) A scheme illustrating the schedule of ionizing radiation (IR) and overall behavioral tests. (<bold>B</bold>) The results of spontaneous alteration (left) and spatial memory test (right) after IR using Y-maze. The parameters of spontaneous alteration and spatial memory are described in methods. (<bold>C</bold>) The result of novel object recognition test after IR. (<bold>D</bold>) Left: representative fluorescence image of filamentous actin (F-actin, green) after IR in cortical neuron. Right: The density and distribution of dendritic spine in IR group compared to control group. Scale bars, 10 μm. (<bold>E</bold>) The alterations of F/G-actin ratio after IR in cortical neuron, frontal cortex, and hippocampus. Statistical analysis was performed with Student’s t-test for (<bold>B</bold>), left of (<bold>C</bold>), and (<bold>E</bold>) and one-way ANOVA plus a Tukey’s multiple comparisons test for (right of <bold>C</bold>) and (<bold>D</bold>) ns, non-significant; *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Western blot data for the level of F/G-actin in cortical neurons, frontal cortex, and hippocampus without or with ionizing radiation (IR).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Cranial radiation affects depressive-like behavior.</title><p>(<bold>A</bold>) The representative heatmaps of open field test after ionizing radiation (IR). (<bold>B</bold>) The result of open field test after IR. Statistical analysis was performed with Student’s t-test. ns, non-significant; ***p&lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Synapse formation on dendrites is known to impact cognitive behavior (<xref ref-type="bibr" rid="bib1">Arendt, 2009</xref>; <xref ref-type="bibr" rid="bib3">Baloyannis, 2009</xref>). Therefore, we examined changes in the dendritic spines of the cortical neurons after IR exposure. Cortical neurons were treated with a single 2 Gy at 14 days in vitro (DIV). Dendritic spine density did not differ between the non-IR and IR groups. In IR-treated neurons, mature dendritic spines (mushroom) were significantly decreased by 37.5%, whereas immature dendritic spines (filopodia) were increased by 37.14% (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The maturation of dendritic spines depends on the F/G-actin ratio (<xref ref-type="bibr" rid="bib10">Chen et al., 2007</xref>; <xref ref-type="bibr" rid="bib66">Rex et al., 2009</xref>). Accordingly, we evaluated whether IR can impact the F/G-actin ratio in neurons. Exposure to IR decreased the F/G-actin ratio in cortical neurons (21.05%), frontal cortex (21.74%), and hippocampus (73.91%) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Overall, these results indicated that IR could induce cognitive impairment by disrupting dendritic spine maturation.</p></sec><sec id="s2-2"><title>IR decreases PAK3-LIMK1-cofilin signaling</title><p>To identify the molecular mechanism of IR-induced dendritic spine alteration, we analyzed microarray data from the brains of mice treated or un-treated with cranial radiation, which was generated in a previous study (GSE94440) (<xref ref-type="bibr" rid="bib40">Kang et al., 2018</xref>). Among the 15 coding genes that were up- and downregulated by cranial irradiation, we focused on the PAK3 gene, which showed a 0.5-fold altered expression in the irradiated brain, considering both the ‘synapse organization’ and the ‘dendritic spine development’ ontologies (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In addition, PAK3 is mainly expressed in the frontal cortex and hippocampus, both crucial regions for cognitive function in the brain (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref> <xref ref-type="bibr" rid="bib11">Christensen et al., 2022</xref>; <xref ref-type="bibr" rid="bib61">Price and Duman, 2020</xref>). As shown in <xref ref-type="fig" rid="fig2">Figure 2B</xref>, IR decreased mRNA and protein levels of PAK3 in cortical neurons (49.48% and 44.30%, respectively). In addition, IR decreased mRNA level of PAK3 in frontal cortex (61.67%) and hippocampus (66.67%) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Based on immunocytochemistry data, PAK3 was localized on dendrites in cortical neurons (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). These results suggested that PAK3, which is correlated with synapses and dendritic spines, is a candidate for IR-induced dendritic spine alteration.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>IR decreases phosphorylation of LIM kinase 1 (LIMK1) and Cofilin via p21-activated kinase 3 (PAK3) downregulation.</title><p>(<bold>A</bold>) The heatmap for the expression of genes in the term ‘synapse organization’ and ‘dendritic spine development’ in the irradiated brain. (<bold>B</bold>) The changes of PAK3 mRNA and protein levels after ionizing radiation (IR) in cortical neuron. Each western blot bands are quantified by ImageJ. (<bold>C</bold>) Representative fluorescence image of filamentous actin (F-actin) (green) and PAK3 (red) in cortical neuron. Scale bars, 10 μm. (<bold>D</bold>) Schematic illustration of PAK3-LIMK1-cofilin signaling. (<bold>E</bold>) Left: the protein levels of phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR in cortical neuron. Right: each western blot bands are quantified by ImageJ. (<bold>F–G</bold>) Representative fluorescence image of F-actin (green) and phosphorylated LIMK1 (<bold>F</bold>), (red) or phosphorylated cofilin (<bold>G</bold>), (red) in cortical neuron. Scale bars, 10 μm. (<bold>H</bold>) Left: the protein levels of phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR in frontal cortex and hippocampus. Right: each western blot bands are quantified by ImageJ. Statistical analysis was performed with Student’s t-test. ns, non-significant; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Western blot data for the level of p21-activated kinase 3 (PAK3) in cortical neurons without or with ionizing radiation (IR).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Western blot data for the levels of phospho-LIMK1, LIM kinase 1 (LIMK1), phospho-Cofilin, Cofilin, and GAPDH in cortical neurons without or with ionizing radiation (IR).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Western blot data for the levels of p21-activated kinase 3 (PAK3), phospho-LIMK1, LIM kinase 1 (LIMK1), phospho-Cofilin, Cofilin, and GAPDH in frontal cortex and hippocampus without or with ionizing radiation (IR).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig2-data3-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>p21-activated kinase 3 (PAK3) is related to synapse organization and dendritic spine development in frontal cortex and hippocampus.</title><p>(<bold>A</bold>) The localization of PAK3 in mouse and three human brain from Allen brain map (<ext-link ext-link-type="uri" xlink:href="https://portal.brain-map.org/">https://portal.brain-map.org/</ext-link>). (<bold>B</bold>) The changes of PAK3 mRNA level after ionizing radiation (IR) in frontal cortex and hippocampus. Statistical analysis was performed with Student’s t-test. **p<italic>&lt;0.01</italic>; ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Oncoprotein 18 (OP18) and tubulin folding cofactor b (TBCB) signaling are not affected by ionizing radiation (IR).</title><p>(<bold>A</bold>) The protein levels of phosphorylated OP18, OP18, TBCB after IR in cortical neuron. (<bold>B</bold>) The protein levels of phosphorylated OP18, OP18, TBCB after IR in frontal cortex and hippocampus.</p><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Western blot data for the levels of phospho-OP18, oncoprotein 18 (OP18), tubulin folding cofactor b (TBCB), and GAPDH in cortical neurons without or with ionizing radiation (IR).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig2-figsupp2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s2sdata2"><label>Figure 2—figure supplement 2—source data 2.</label><caption><title>Western blot data for the levels of phospho-OP18, oncoprotein 18 (OP18), tubulin folding cofactor b (TBCB), and GAPDH in frontal cortex and hippocampus without or with ionizing radiation (IR).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig2-figsupp2-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig2-figsupp2-v1.tif"/></fig></fig-group><p>Given that PAK3 inhibits severing and promotes the branching of F-actin (<xref ref-type="bibr" rid="bib64">Rane and Minden, 2014</xref>), we further examined actin dynamics-related PAK3 signaling. PAK3 phosphorylates LIMK1 to activate it, and activated LIMK1, in turn, phosphorylates cofilin to its inactive state. Activated cofilin promotes actin turnover, while inactivated cofilin suppresses actin turnover (<xref ref-type="fig" rid="fig2">Figure 2D</xref>; <xref ref-type="bibr" rid="bib4">Bamburg et al., 2021</xref>; <xref ref-type="bibr" rid="bib20">Edwards et al., 1999</xref>). Therefore, we examined whether IR can affect the activation of LIMK1 and cofilin. Herein, we observed that IR decreased the expression of phosphorylated LIMK1 and cofilin in cortical neurons, frontal cortex, and hippocampus (<xref ref-type="fig" rid="fig2">Figure 2E and H</xref>). In addition, phosphorylated LIMK1 and cofilin were less expressed and localized on the dendrites in cortical neurons (<xref ref-type="fig" rid="fig2">Figure 2F and G</xref>). These results suggested that IR could decrease the activation and localization of LIMK1 and cofilin in dendritic spines by downregulating PAK3 expression. However, IR did not alter other downstream factors related to cytoskeleton regulation, such as OP18 and tubulin-folding cofactor B (TBCB) (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Overall, these results showed that IR decreased the expression and localization of PAK3, which, in turn, decreased the phosphorylation of LIMK1 and cofilin.</p></sec><sec id="s2-3"><title>PAK3 regulates dendritic spine morphology and maturation</title><p>Given that PAK3 is associated with synapse organization and dendritic spine development, we further examined whether the regulation of PAK3 could impact dendritic spines. First, we knocked down PAK3 using a short hairpin RNA (shRNA). Every two shRNAs targeting PAK3 successfully reduced the mRNA level of PAK3 by approximately 30% (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We employed shRNA #1 to examine the effects of PAK3 downregulation. Downregulated PAK3 expression reduced the F/G-actin ratio (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) and LIMK1-cofilin signaling (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Dendritic spines were observed after PAK3 downregulation. We noted that the dendritic spine density did not differ between the control and PAK3 downregulation groups. However, the number of mushroom spines was lower than that of filopodia following PAK3 downregulation (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Compared with the filopodia spine, the mushroom spine is a more mature form that typically transmits nerve signals to other neurons (<xref ref-type="bibr" rid="bib29">Hering and Sheng, 2001</xref>). We examined the effects of PAK3 overexpression (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). PAK3 overexpression affects the expression and phosphorylation of LIMK1 and cofilin. We evaluated the recovery of IR-induced downregulated PAK3 signaling after PAK3 overexpression. Notably, PAK3 overexpression could restore IR-induced downregulation of F/G-actin (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Following alterations in the F/G-actin ratio, mushroom spines were more abundant than filopodia in IR-treated PAK3 overexpressing neurons (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). These results suggested that PAK3 could regulate the F/G-actin ratio and maturation of the dendritic spine through LIMK1-cofilin signaling. Considering IR-induced decreased PAK3 signaling, upregulation of PAK3 expression could restore the F/G-actin ratio and dendritic spine distribution to normal levels in murine neurons.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>p21-activated kinase 3 (PAK3) regulates filamentous/globular (F/G)-actin and dendritic spine in neuron.</title><p>(<bold>A</bold>) The changes of PAK3 mRNA levels after PAK3 downregulation (shPAK3) in cortical neuron. (<bold>B</bold>) The F/G-actin ratio after expression of PAK3 downregulation (shPAK3) in cortical neuron. Each filamentous actin (F-actin) and globular (G)-actin are quantified by ImageJ. (<bold>C</bold>) The protein levels of phosphorylated LIMK1, LIM kinase 1 (LIMK1), phosphorylated cofilin, and cofilin after PAK3 downregulation (shPAK3) in cortical neuron. (<bold>D</bold>) Upper: representative fluorescence image of filamentous actin (F-actin, green) after PAK3 downregulation (shPAK3) in cortical neuron. Lower: the density and distribution of dendritic spine in shPAK3 group compared to control group. Scale bars, 10 μm. (<bold>E</bold>) The protein levels of PAK3, phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after PAK3 overexpression in cortical neuron. (<bold>F</bold>) The F/G-actin ratio after ionizing radiation (IR) or IR with PAK3 overexpression in cortical neuron. Each F-actin and G-actin are quantified by ImageJ. (<bold>G</bold>) Upper: representative fluorescence image of filamentous actin (F-actin, green) after IR and/or PAK3 overexpression in cortical neuron. Lower: the density and distribution of dendritic spine in control, IR and/or PAK3 overexpression group. Scale bars, 10 μm. Statistical analysis was performed with Student’s t-test for (<bold>B</bold> and <bold>D</bold>) and one-way ANOVA plus a Tukey’s multiple comparisons test for (<bold>A, D, F</bold>, and <bold>G</bold>) ns, non-significant; *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Western blot data for the level of F/G-actin in cortical neurons without or with p21-activated kinase 3 (PAK3) downregulation.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig3-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Western blot data for the levels of p21-activated kinase 3 (PAK3), phospho-LIMK1, LIM kinase 1 (LIMK1), phospho-Cofilin, Cofilin, and GAPDH in cortical neurons without or with PAK3 downregulation.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Western blot data for the levels of LIM kinase 1p21-activated kinase 3 (PAK3), phospho-LIMK1, LIM kinase 1 (LIMK1), phospho-Cofilin, Cofilin, and GAPDH in cortical neurons without or with PAK3 upregulation.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig3-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Western blot data for the level of F/G-actin in cortical neurons in control, ionizing radiation (IR), and IR with p21-activated kinase 3 (PAK3) overexpression.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig3-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig3-v1.tif"/></fig><p>To explore whether IR can decrease PAK3 signaling and dendritic spine maturation in human neurons, we differentiated neural progenitor cells into neurons. Herein, we observed that the expression of stemness markers (SOX2, Nestin, and PAX6) was decreased in differentiated neurons (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). In addition, the expression of neuronal (NeuN) and synaptic (PSD95) markers was increased in differentiated neurons when compared with that in neural progenitor cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). The altered expression of markers suggests that human neural progenitor cells can differentiate into human neurons. Therefore, differentiated neurons were used to confirm alterations in human neurons. IR decreased neuronal viability in human differentiated neurons, with approximately 80% survival (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). However, IR did not alter the mature neuronal marker, NeuN (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). These results indicate that IR-induced disruption of PAK3 signaling occurs in surviving neurons following irradiation. Consistent with previous murine neuron data, IR reduced the F/G-actin ratio (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Based on IR-induced altered F/G-actin ratio, we hypothesized that IR could reduce PAK3-LIMK1-cofilin signaling in differentiated neurons. IR decreased the expression of PAK3, phosphorylated-LIMK1, and phosphorylated-cofilin in human neurons (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). A previous study has revealed that IR can reduce mature dendritic spines and enhance immature dendritic spines (<xref ref-type="fig" rid="fig1">Figure 1D</xref>); IR downregulated the mature dendritic spine and upregulated the immature dendritic spine in human neurons (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). To confirm that these changes were caused by IR-induced PAK3 downregulation, we used shRNA to downregulate PAK3 expression in differentiated neurons. Consistent with the IR effect on dendritic spines, downregulated PAK3 expression increased the number of immature dendritic spines (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Collectively, PAK3 signaling is essential for the maturation of dendritic spines, and IR could disrupt PAK3 signaling in human neurons.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>IR decreases PAK3-LIMK1-Cofilin signaling in differentiated human neuron.</title><p>(<bold>A</bold>) The filamentous/globular (F/G)-actin ratio after IR in differentiated neuron. Each F-actin and G-actin are quantified by ImageJ. (<bold>B</bold>) The mRNA level of p21-activated kinase 3 (PAK3) after ionizing radiation (IR) in differentiated neuron. (<bold>C</bold>) The protein levels of PAK3, phosphorylated LIMK1, LIM kinase 1 (LIMK1), phosphorylated cofilin, and cofilin after IR in differentiated neuron. (<bold>D</bold>) Upper: representative fluorescence image of filamentous actin (F-actin, green) after IR in differentiated neuron. Lower: the density and distribution of dendritic spine in IR group compared to control group. Scale bars, 10 μm. (<bold>E</bold>) Upper: representative fluorescence image of filamentous actin (F-actin, green) after PAK3 downregulation (shPAK3) in differentiated neuron. Lower: the density and distribution of dendritic spine in shPAK3 group compared to control group. Scale bars, 10 μm. Statistical analysis was performed with Student’s t-test for (<bold>A, B, D </bold>and <bold>E</bold>) and one-way ANOVA plus a Tukey’s multiple comparisons test for (<bold>D</bold> and <bold>E</bold>) ns, non-significant; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Western blot data for the level of F/G-actin in differentiated neurons without or with ionizing radiation (IR).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig4-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Western blot data for the levels of p21-activated kinase 3 (PAK3), phospho-LIMK1, LIM kinase 1 (LIMK1), phospho-Cofilin, Cofilin, and GAPDH in differentiated neurons without or with ionizing radiation (IR).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig4-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Neural progenitor cell is differentiated into human neuron.</title><p>(<bold>A</bold>) The mRNA levels of SOX2, Nestin, and PAX6 in neural progenitor cell and differentiated neuron. (<bold>B</bold>) The protein levels of PSD95, NeuN, SOX2, and GAPDH. Statistical analysis was performed with Student’s t-test. ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Western blot data for the levels of PSD95, NeuN, SOX2, and GAPDH in neural progenitor cells and differentiated neurons.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig4-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>IR-induced miR-206-3p decreases PAK3 expression, and its inhibition rescued PAK3 signaling</title><p>To elucidate the mechanism underlying IR-induced changes in PAK3 expression, we performed a luciferase reporter assay for the <italic>Pak3</italic> promoter. In murine neurons, IR failed to induce any change in luciferase activity (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), suggesting that IR does not induce PAK3 expression by regulating transcription levels. Next, we hypothesized that IR might alter the miRNAs targeting PAK3. Using miRNA databases (miRDB, TargetScan, and TarBase), we analyzed miRNAs targeting PAK3, selecting three miRNA candidates (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Among the three miRNAs, IR significantly upregulated only miR-206–3 p in both mice and humans (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). To validate whether IR can impact miR-206–3 p expression and examine the effects of miR-206–3 p inhibition, we determined miR-206–3 p levels after IR and treatment with an inhibitor of miR-206–3 p (antagomiR-206–3 p). IR increased miR-206–3 p expression in both mouse and human neurons (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). In addition, antagomiR-206–3 p successfully inhibited IR-induced miR-206–3 p expression in mouse and human neurons (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Consistent with the miRNA inhibition data, IR-induced PAK3 downregulation was restored to approximately 90% of the control in both neurons (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). To confirm whether miR-206–3 p could affect PAK3 signaling, we examined whether treatment with miR-206–3 p could alter PAK3-LIMK1-cofilin signaling. As expected, miR-206–3 p decreased PAK signaling, and the respective antagonist partially restored the downregulated PAK3 signaling (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>). Additionally, the post-synaptic marker, PSD-95, was decreased by miR-206–3 p treatment. However, a mature neuronal marker (NeuN) and non-neuronal markers (GFAP and IBA-1) were not altered upon miR-206–3 p treatment (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). In addition, consistent with the effects of antagomiR, IR disrupted the distribution of dendritic spines, and IR with antagomiR treatment restored dendritic spine maturation (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). These results suggested that IR-induced miR-206–3 p decreased PAK3 signaling and dendritic spine maturation in mouse and human neurons.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>IR-induced miR-206–3 p affects PAK3-LIMK1-cofilin signaling.</title><p>(<bold>A</bold>) The relative luciferase activity of PAK3 promoter after ionizing radiation (IR) in cortical neuron. (<bold>B</bold>) Venn diagram of predictable PAK3-targeting miRNAs from databases (miRDB, TargetScan, and TarBase). (<bold>C</bold>) The relative miRNA expression of three overlapped miRNAs after IR in cortical neuron and differentiated neuron. (<bold>D</bold>) The relative miRNA expression of miR-206–3 p after IR and/or antagomiR-206–3 p treatment in cortical neuron and differentiated neuron. (<bold>E</bold>) The mRNA level of PAK3 after IR and/or treatment of antagomiR-206–3 p in cortical neuron and differentiated neuron. (<bold>F</bold>) The protein levels of PAK3, phosphorylated LIMK1, LIM kinase 1 (LIMK1), phosphorylated cofilin, and cofilin after treatment of miR-206–3 p mimic in differentiated neuron. (<bold>G</bold>) The protein levels of p21-activated kinase 3 (PAK3), phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR and/or treatment of antagomiR-206–3 p in differentiated neuron. (<bold>H</bold>) Upper: representative fluorescence image of filamentous actin (F-actin, green) after IR and/or treatment of antagomiR-206–3 p in cortical neuron. Lower: the density and distribution of dendritic spine in control, IR and/or treatment of antagomiR-206–3 p group. Scale bars, 10 μm. Statistical analysis was performed with Student’s t-test for (<bold>A</bold>) and one-way ANOVA plus a Tukey’s multiple comparisons test for the others. ns, non-significant; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Western blot data for the levels of p21-activated kinase 3 (PAK3), phospho-LIMK1, LIM kinase 1 (LIMK1), phospho-Cofilin, Cofilin, and GAPDH in differentiated neurons without or with the treatment of miR-206–3 p mimic.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig5-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Western blot data for the level of F/G-actin in differentiated neurons in control, ionizing radiation (IR), and IR with the treatment of antagomiR-206–3 p.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig5-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>miR-206–3 p affects only PSD-95 but not other neuronal and non-neuronal markers.</title><p>(<bold>A</bold>) The mRNA levels of NeuN and PSD-95 after IR 2 Gy or miR-206–3 p in differentiated neuron. (<bold>B</bold>) The mRNA levels of IBA-1 and GFAP after IR 2 Gy or miR-206–3 p in differentiated neuron. Statistical analysis was performed with one-way ANOVA plus a Tukey’s multiple comparisons test. ns, non-significant; **p&lt;0.01; ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig5-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Intranasal administration of antagomiR-206-3p rescues cognitive function</title><p>Given that antagomiR for miR-206–3 p effectively attenuated IR-mediated alterations in dendritic spines, we next inhibited miR-206–3 p to recover cognitive impairment in vivo. To efficiently deliver antagomiR to the brain, antagomiR was administered intranasally. Intranasal administration is a less invasive method for drug delivery, easily accessible to adult and pediatric patients. According to the previous in vivo experimental protocol (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), mice were exposed to IR with five fractions (over a 24 hr interval) of 2 Gy to the cranial region and subsequently treated with antagomiR via intranasal administration. Then, OPF, Y-maze, and NOR tests were performed from days 2–7 post-intranasal administration. Behavioral tests were performed according to the overall schedule (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). We then administered Cy5-labeled antagomiR to IR-treated mice via intranasal administration (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). To validate the delivery efficiency of antagomiR, we examined Cy5 fluorescence in the brain after intranasal administration (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Treatment with Cy5-antagomiR treatment dose-dependently increased Cy5 fluorescence. As the frontal cortex and hippocampus are cognition-related central regions in the brain (<xref ref-type="bibr" rid="bib11">Christensen et al., 2022</xref>; <xref ref-type="bibr" rid="bib32">Hogeveen et al., 2022</xref>; <xref ref-type="bibr" rid="bib61">Price and Duman, 2020</xref>; <xref ref-type="bibr" rid="bib69">Sakimoto et al., 2021</xref>), we confirmed IR and antagomiR effects in the frontal cortex and hippocampus. Consistent with in vitro results (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), antagomiR decreased the IR-induced miR-206–3 p expression in the frontal cortex and hippocampus (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). IR-treated mice administered antagomiR exhibited attenuated spontaneous alteration, as well as time in the novel arm and time spent with the novel object (<xref ref-type="fig" rid="fig6">Figure 6E and F</xref>). In addition, time spent in the center of the OPF was restored in IR-treated mice administered antagomiR (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). These results showed that antagomiR could successfully attenuate IR-induced cognitive impairment. To validate whether antagomiR-induced recovery of cognitive function is mediated via the restoration of PAK3 signaling to normal levels, we confirmed that antagomiR restored IR-induced downregulation of PAK3 signaling. Consistently, antagomiR treatment increased the expression of PAK3, phosphorylated-LIMK1, and phosphorylated-cofilin in the frontal cortex and hippocampus (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). In addition, the F/G-actin ratio in the frontal cortex and hippocampus was restored to normal when compared with that in the IR-treated group (<xref ref-type="fig" rid="fig6">Figure 6H</xref>). Collectively, these results suggested that antagomiR could be an effective strategy for IR-induced cognitive impairment by restoring PAK3 signaling.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Intranasal administration of antagomiR-206–3 p recovers p21-activated kinase 3 (PAK3) signaling and cognitive impairment after ionizing radiation (IR).</title><p>(<bold>A</bold>) A scheme illustrating the schedule of IR and antagomiR-206–3 p treatment and overall behavioral tests. (<bold>B</bold>) Schematic illustration of antagomir-206–3 p delivery via intranasal administration. (<bold>C</bold>) The fluorescence images and relative units of cy5-antagomiR-206–3 p in the brain of mice 24 hr after intranasal administration. (<bold>D</bold>) The relative miRNA expression of miR-206–3 p after IR and/or antagomiR-206–3 p treatment in frontal cortex and hippocampus. (<bold>E</bold>) The results of spontaneous alteration (left) and spatial memory test (right) after IR and/or antagomiR-206–3 p using Y-maze. The parameters of spontaneous alteration are described in methods. (<bold>F</bold>) The result of novel object recognition test after IR and/or antagomiR-206–3 p. (<bold>G</bold>) The protein levels of PAK3, phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR and/or treatment of antagomiR-206–3 p in frontal cortex and hippocampus. (<bold>H</bold>) The alterations of F/G-actin ratio after IR and/or treatment of antagomiR-206–3 p in frontal cortex and hippocampus. Statistical analysis was performed with one-way ANOVA plus a Tukey’s multiple comparisons test. ns, non-significant; **p&lt;0.01; ***p&lt;0.001; ****p&lt;0.0001.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Western blot data for the levels of p21-activated kinase 3 (PAK3), phospho-LIMK1, LIM kinase 1 (LIMK1), phospho-Cofilin, Cofilin, and GAPDH in frontal cortex and hippocampus in control, ionizing radiation (IR), and IR with treatment of antagomiR-206–3 p.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig6-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Western blot data for the level of F/G-actin in frontal cortex and hippocampus in control, ionizing radiation (IR), and IR with treatment of antagomiR-206–3 p.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-89221-fig6-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>AntagomiR-206–3 p attenuates depressive-like behavior.</title><p>(<bold>A</bold>) The representative heatmaps of open field test after ionizing radiation (IR) or IR with antagomiR-206–3 p. (<bold>B</bold>) The result of open field test after IR or IR with antagomiR-206–3 p. Statistical analysis was performed with one-way ANOVA plus a Tukey’s multiple comparisons test. ns, non-significant; ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Summary of alterations to p21-activated kinase 3 (PAK3) signaling in dendritic spine upon ionizing radiation (IR) exposure.</title><p>Cranial irradiation impairs the maturation of dendritic spines by decreasing PAK3 signaling. Briefly, cranial irradiation increases miR-206–3 p, which targets PAK3 and decreases its levels. Decreased PAK3 reduces the phosphorylation of LIMK and cofilin, resulting in decreased actin polymerization. This leads to a reduction in the ratio of F-actin to G-actin, which in turn impairs the maturation of dendritic spines. As a result, cognitive function is impaired via dendritic spines.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89221-fig6-figsupp2-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Radiotherapy is a common treatment for cancer to stop or prevent cancer cells from growing or spreading in the body. In particular, PCI is widely used for preventing brain metastasis, but it may cause side effects including cognitive impairment, which significantly impacts the quality of life of patients. In this study, we investigated the effect of cranial irradiation on cognitive function and the underlying neuronal mechanisms using in vivo and in vitro models. Our results revealed that cranial irradiation reduced cognitive function and downregulated the expression of PAK3, a gene involved in dendritic spine development and synaptic plasticity in the frontal cortex and hippocampus. We demonstrated that the PAK3-LIMK1-cofilin signaling pathway was affected by IR, leading to dendritic spine maturation impairment. Additionally, we found that miR-206–3 p regulated PAK3 expression and that antagomiR-206–3 p treatment restored PAK3 levels and cognitive function in the irradiated mice. Our findings suggest that PAK3 may play a critical role in cognitive function after cranial irradiation, highlighting a potential therapeutic target to mitigate the adverse effects of radiotherapy (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>).</p><p>PAK3 expression is altered in several neurodegenerative diseases, suggesting that the decrease in PAK3 may be partly involved in cognitive or developmental symptoms. PAK3 mRNA levels are significantly reduced in the hippocampus of subjects affected with depression (<xref ref-type="bibr" rid="bib23">Fuchsova et al., 2016</xref>). Additionally, in post-mortem brains of Down syndrome and AD patients, PAK3 proteins are markedly reduced with abnormal cofilin activation in neurites (<xref ref-type="bibr" rid="bib48">Lauterborn et al., 2020</xref>). Consistent with our study, decreased PAK3 impairs cognitive function via regulation of the dendritic spine in neurodegenerative diseases. In addition to dendritic spine morphology regulation, PAK3 involves in synaptic transmission and trafficking. For example, PAK3 controls the surface trafficking of the major excitatory receptor GluA1 AMPA receptor subunit in neurons (<xref ref-type="bibr" rid="bib36">Hussain et al., 2015</xref>). PAK3 can also control synaptic GABA(A)R surface stability via G protein-coupled receptor kinase interacting with ArfGAP 1/βPIX signaling (<xref ref-type="bibr" rid="bib74">Smith et al., 2014</xref>). These results suggest that PAK3 plays a key role in regulating synaptic function as well as the dendritic spine morphology.</p><p>Previous studies have shown that the activation of PAK3 is primarily regulated by phosphorylation (<xref ref-type="bibr" rid="bib51">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib83">Wu and Jiang, 2022</xref>), and phosphorylated PAK3 is correlated to activity of AMPA receptor (<xref ref-type="bibr" rid="bib36">Hussain et al., 2015</xref>), neuroplasticity (<xref ref-type="bibr" rid="bib42">Kim et al., 2017</xref>), spine morphogenesis (<xref ref-type="bibr" rid="bib86">Zhang et al., 2005</xref>), and neurite outgrowth (<xref ref-type="bibr" rid="bib71">Shin et al., 2006</xref>). On the contrary, our study demonstrated that a decrease in PAK3 expression alone can significantly alter spine morphogenesis. This finding suggests that PAK3 expression levels may be a critical determinant of dendritic spine development and synaptic plasticity, even regardless of the phosphorylation status. Furthermore, our study identifies a potential mechanism underlying the cognitive impairment associated with cranial irradiation, which downregulates PAK3 expression. These results highlight the importance of PAK3 expression in cognitive function and provide a potential therapeutic target for reducing the adverse effects of cranial irradiation on brain function.</p><p>The dendritic spine is one of the major factors influencing cognitive function. In our study, we observed changes in dendritic spines due to radiation exposure, followed by subsequent cognitive impairment. Additionally, we established that regulating PAK3, which affects dendritic spine maturation, can modulate radiation-induced cognitive dysfunction. However, considering that radiation can impact the entire nervous system and that neural circuit function, neuroinflammation, and astrogliosis can also influence cognitive function (<xref ref-type="bibr" rid="bib53">Makale et al., 2017</xref>), future studies are needed to investigate the mechanisms of factors beyond dendritic spine changes caused by radiation.</p><p>Intranasal administration can bypass the blood-brain barrier and rapidly deliver drugs from the nasal mucosa to the brain in a non-invasive way and reducing systemic side effects (<xref ref-type="bibr" rid="bib14">Corrigan et al., 2015</xref>; <xref ref-type="bibr" rid="bib79">Tucker et al., 2018</xref>). Recent studies reported that intranasal insulin administration for the treatment of CNS disorders including mild cognitive impairment and AD (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> Identifier: NCT01767909, <xref ref-type="bibr" rid="bib16">Craft et al., 2020</xref>). Additionally, previous studies reported that intranasal administration of microRNA is effective in ischemic brain injury (<xref ref-type="bibr" rid="bib49">Lawson et al., 2022</xref>), depression (<xref ref-type="bibr" rid="bib27">Guan et al., 2021</xref>), and AD (<xref ref-type="bibr" rid="bib52">Mai et al., 2019</xref>). In this study, we demonstrated the potential utility of intranasal administration of antagomiR-206–3 p for restoring PAK3 levels and cognitive function in irradiated mouse models with marginal side effects. Other advantages of intranasal administration include avoiding the gastrointestinal tract or hepatic metabolism (<xref ref-type="bibr" rid="bib55">Mistry et al., 2009</xref>), and enhancing drug bioavailability and stability (<xref ref-type="bibr" rid="bib62">Quintana et al., 2016</xref>). A previous study reported that drug absorption through the nasal cavity is more efficient than through the gastrointestinal tract (<xref ref-type="bibr" rid="bib24">Furubayashi et al., 2007</xref>). In addition, intranasal administration of biomacromolecular agents, including nucleic acid-based drugs, remarkably reduced the degradation rate and increased the delivery efficiency compared to the oral route (<xref ref-type="bibr" rid="bib22">Fortuna et al., 2014</xref>). Collectively, intranasal administration provides a promising avenue for targeting and delivery to the brain with little adverse effects.</p><p>Overall, our study highlights the detrimental effects of cranial irradiation on cognitive function and provides new insights into the role of PAK3 in dendritic spine development and cognitive function. We provide the underlying mechanisms of PAK3-associated cognitive impairment after radiotherapy using both differentiated human neurons and mouse models. Considering the high delivery efficiency and the anti-cognitive impairment effects of antagomiR-206–3 p from our preclinical results, intranasal administration of antagomiR-206–3 p may offer a promising approach for reducing the adverse effects of PCI.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p>7-week-old male C57BL/6 mice (Orient Bio, Republic of Korea) were used for the in vivo experiments. All experiments were performed in accordance with the provisions of the NIH Guide for the Care and Use of Laboratory Animals. The mice were housed individually or in groups of up to five in sterile cages, and were maintained in animal care facilities in a temperature-regulated room (23 ± 1℃) with a 12 hr light-dark cycle. All animals were fed water and standard mouse chow ad libitum. The sample size was determined based on ethical considerations in animal research and took into account various parameters, including an effect size of 1.2, an alpha value of 0.05, and three groups. This resulted in a total sample size of 15, with five mice per group, as calculated using G Power 3.1 software.</p></sec><sec id="s4-2"><title>Cell line</title><p>ReNcell VM Human Neural Progenitor Cell Line (Millipore Cat. No. SCC008) was used in this study. In brief, the plates were coated with laminin (20 μg/mL) for 4 hr, after which cells were seeded onto these coated plates and cultured in a medium containing FGF-2 (20 ng/mL) and EGF (20 ng/mL). For neuronal differentiation, the medium was replaced with a medium without FGF-2 and EGF. Then, the medium was replaced with a fresh one every 2–3 days for two weeks. Differentiation was confirmed by the expression of neuronal markers.</p></sec><sec id="s4-3"><title>Irradiation</title><p>All mice, including those in the sham (0 Gy) group, were anesthetized with an intraperitoneal (i.p.) injection of zoletil (5 mg/10 g) daily for 5 days. After sufficient anesthesia was induced, the mice were attached to a fixed plate, and irradiation was applied at locations ranging from 0.3 cm behind the eyes to the posterior part of both ears to ensure that the radiation surface did not involve the eyes, mouth, and spinal cord (to prevent the normal exercise ability of the mouse from being affected by irradiation). The brain of mice were irradiated with 2 Gy daily for five days at a dose rate of 600 MU/min using a TrueBeam STx.</p></sec><sec id="s4-4"><title>Behavior: Open field test</title><p>Depressive-like behavior of mice was assessed in rectangular chambers (Width × Length × Depth = 50 cm × 50 cm × 38 cm). Mice were habituated for 3 min in the chamber (without recording) and then placed for another 5 min in the center of the chamber (with recording). Localization was recorded and analyzed by the time in the center zone using Noldus EthoVision XT software (Noldus Information Technology, Leesburg, VA).</p></sec><sec id="s4-5"><title>Behavior: Y-maze</title><p>Spontaneous alteration was measured using a Y-maze apparatus (three gray opaque plastic, symmetrical arm, length: 40 cm, arm bottom width: 3 cm, arm upper width: 13 cm, height of wall: 15 cm, angled at 120°, Busan, South Korea). Each mouse was placed in the central area. The number of entries into the arms and alterations were recorded for 10 min with the EthoVisionXT video-imaging system. Max alternation was defined as the number of possible alternations counted by the total number of arms entered minus 2. Alternation was defined as consecutive entries into three different arms and counted only if a mouse entered into the three arms of the maze (without revisiting the first arm at the third visit) (<xref ref-type="bibr" rid="bib33">Hölter et al., 2015</xref>).</p><p>Spatial memory was tested by placing the test mouse into the Y-maze with one arm of the maze closed off during training (Training session). This arm is designated as the novel arm. After 4 hr, during which the mouse is removed from the maze, the mouse is placed back into the maze with the blockage removed (Testing session). The number of entries into the novel arm was recorded for 10 min with the EthoVisionXT video-imaging system (<xref ref-type="bibr" rid="bib44">Kraeuter et al., 2019</xref>).</p></sec><sec id="s4-6"><title>Behavior: Novel object recognition (NOR)</title><p>NOR assay was used to explore cognitive performance in the long-term memory in a 50 × 50 cm opaque square arena. On Day 1, the mice were habituated to an open field arena for 5 min. On Day 2, the mice were exposed to two identical objects for a 5 min period. On Day 3, one of the objects was replaced with a new object, and the mice were let to explore the arena for 5 min. Each trial was recorded and the videos were automatically analyzed by EthoVision XT software (Noldus). The time spent with the familiar and novel objects was measured (<xref ref-type="bibr" rid="bib68">Rungratanawanich et al., 2019</xref>).</p></sec><sec id="s4-7"><title>Intranasal administration</title><p>According to the manufacturer’s instructions and previous study (<xref ref-type="bibr" rid="bib89">Zhou et al., 2021</xref>), 40 nmol of antagomiR-206–3 p (sequence: 5’-<named-content content-type="sequence">CCACACACUUCCUUACAUUCCA</named-content> –3’) or antagomiR-NC (the antagomiR negative control, its antisense chain sequence: 5’-<named-content content-type="sequence">UCUACUCUUUCUAGGAGGUUGUGA</named-content>-3’) was dissolved in 1 mL of RNase-free water. A total of 24 μL of the solution (1 nmol per one mouse) was instilled with a pipette, alternately into the left and right nostrils (1 μL/time), with an interval of 3–5 min. The respiration of mice was not blocked, and other disorders were not observed; all mice in different groups survived. The same dosage and mode of administration were used for intranasal Cy5-antagomiR-206–3 p administration (n = 3) to trace the distribution of antagomiR-206–3 p after administration. We observed the overall and its sagittal section of the brain using ChemiDoc at 24 hr after intranasal administration of Cy5-antagomiR-206–3 p.</p></sec><sec id="s4-8"><title>Dissection of prefrontal cortex and hippocampus</title><p>The dissection of mouse brain regions was performed following a previous study (<xref ref-type="bibr" rid="bib75">Spijker, 2011</xref>). First, to obtain the hippocampal region, we gently held the brain and opened the forceps, slowly separating the cortical halves. Once an opening had been created along the midline for approximately 60%, we directed the forceps (in the closed position) counterclockwise by 30–40° to expose the left cortex from the hippocampus, repeatedly opening the forceps as necessary. We then repeated the same procedure for the right cortex by pointing the forceps in a 30–40°C lockwise direction until the upper part of the hippocampus became visible. At the most caudal part of the hippocampus/cortex boundary, we moved the small forceps through the cortex and used them to separate the hippocampus from the fornix. After removing the hippocampus, we used the large forceps to fold the cortex back into its original position. Subsequently, we placed the brain with the dorsal side and cut coronal sections to reveal the prefrontal cortex and striatum at different levels. Using a sharp razor blade, we made the first cut to remove the olfactory bulb and cut the section containing the prefrontal cortex.</p></sec><sec id="s4-9"><title>Primary neuronal cell culture</title><p>As a previous study reported (<xref ref-type="bibr" rid="bib43">Kim et al., 2022</xref>), pregnant C57BL/6 mice were obtained from a specific pathogen-free colony at Oriental Inc (Seoul, Korea). Embryos were dissected from embryonic day 15.5 mice and prepared for culturing. The prefrontal cerebral cortices were dissected under sterile conditions, and the meninges were pulled off. As a previous study, the brain was cut into 200–400 mm sections, starting from the olfactory bulb (<xref ref-type="bibr" rid="bib30">Hilgenberg and Smith, 2007</xref>). Once the blade enters the cortex, begin cutting 600 µm coronal sections. The appropriate slices obtained after sectioning were used for the primary culture. The prefrontal cerebral cortices were then digested with 2.5% Trypsin-EDTA (Gibco BRL) in DMEM media for 15 min at 37°C. After digestion, cells were dispersed through a pipette and filtered through a 70 μm nylon net filter. The cells were then centrifuged 5 min at 500 g; washed with Neurobasal medium containing B27 serumfree supplement (Thermo Scientific) and penicillin/streptomycin (Thermo Scientific). The cultured cells were incubated at 37°C in a humidified atmosphere of 5% CO2. In the analysis of molecular alterations, cultured neurons were sampled 4 days after irradiation.</p></sec><sec id="s4-10"><title>Cell transfection</title><p>The knockdown of PAK3 was performed by shRNA. Cells were seeded in appropriate culture dishes before transfection. They were then treated with mouse shRNA targeting PAK3: shPAK3#1 (target sequence: <named-content content-type="sequence">CGCCGCAAAGGAAGCAATTAA</named-content>), shPAK3#2 (target sequence: <named-content content-type="sequence">CGGTCAACAACCAGAAATATA</named-content>), or shRNA specific for differentiated neurons (shPAK3 with target sequence: <named-content content-type="sequence">CAACCCAAGAAGGAATTAATT</named-content>), using Lipofectamine 3000 Transfection Reagent (Invitrogen). After 48 hr of transfection, further analyses were conducted.</p></sec><sec id="s4-11"><title>Image analysis</title><p>Primary cultured neuron and differentiated neuron were attached by a poly-d lysine–coated and laminin-coated confocal plate, respectively. Cells were fixed in 4% paraformaldehyde (5 min) and permeabilized with 0.1% Triton X-100 in PBS with 5% BSA (10 min). After blocking with 1% BSA in PBS (30 min), primary antibodies were incubated overnight at 4°C and stained with secondary antibodies for 1 hr. Coverslips were mounted with Fluoromount aqueous mounting medium. Samples were imaged with a confocal microscope (LSM 800 system). The microscopes were controlled by Zeiss black edition software. Secondary antibodies were labeled with Alexa Fluor 488, or 594.</p></sec><sec id="s4-12"><title>Dendritic spine distribution</title><p>The images of entire neurons were acquired at 20 X magnification. For spine counts, the images were analyzed using a semiautomated analysis software (NeuronJ) publicly available at <ext-link ext-link-type="uri" xlink:href="https://imagescience.org/meijering/software/neuronj/manual/">https://imagescience.org/meijering/software/neuronj/manual/</ext-link> (<xref ref-type="bibr" rid="bib88">Zhang et al., 2022</xref>). Whole dendrite was subdivided into segments of 1 μm and the number of spines across the whole thickness was traced for the length and breadth of each spine. Length and breadth ratio was used to determine the spine subtype as described earlier (<xref ref-type="bibr" rid="bib2">Bączyńska et al., 2021</xref>). After the analysis for each class of spine, standard deviation and p-values are calculated using two-way ANOVA with Sidak’s multiple comparison method.</p></sec><sec id="s4-13"><title>Real-time qRT-PCR</title><p>The expression levels of mRNAs, miRNAs, and stemness and neuron-related genes were analyzed by real-time qRT-PCR, as previously described (<xref ref-type="bibr" rid="bib72">Shin et al., 2022</xref>). Aliquots of the master mix containing all of the reaction components with the primers were dispensed into a real-time PCR plate (Applied Biosystems, Foster City, CA, USA). All PCR reagents were from a SYBR Green core reagent kit (Applied Biosystems). The expressions of all genes were measured in triplicate in the reaction plate. The qRT-PCR was performed using the StepOne Real-Time PCR System (Applied Biosystems). It was performed by subjecting the samples at 95°C for 15 s and at 60°C for 1 min for 40 cycles followed by thermal denaturation. The expression of each gene relative to <italic>Gapdh</italic> mRNA was determined using the 2<sup>−ΔΔCT</sup> method.</p></sec><sec id="s4-14"><title>F/G-actin ratio</title><p>F/G-actin ratio was assessed as previously described (<xref ref-type="bibr" rid="bib21">Festa et al., 2020</xref>). Briefly, cells were lysed in cold lysis buffer [10 mM K<sub>2</sub>PO<sub>4</sub>, 100 mM NaF, 50 mM KCl, 2 mM MgCl<sub>2</sub>, 1 mM EGTA, 0.2 mM DTT, 0.5% Triton-X 100, 1 mM sucrose (pH 7.0)] and centrifuged at 15,000 × g for 30 min. Separation of F-actin and G-actin was achieved in that F-actin is insoluble (pellet) in this buffer, whereas G-actin is soluble (supernatant). The G-actin supernatant was transferred to a fresh tube and the F-actin pellet was resuspended in lysis buffer plus an equal volume of a second buffer [1.5 mM guanidine hydrochloride, 1 mM sodium acetate, 1 mM CaCl<sub>2</sub>, 1 mM ATP, 20 mM tris-HCl (pH 7.5)] and then incubated on ice for 1 hr with gentle mixing every 15 min to convert F-actin into soluble G-actin. Samples were centrifuged at 15,000 × g for 30 min and the supernatant (containing F-actin which was converted to G-actin) was transferred to a fresh tube. F-actin and G-actin samples were loaded with equal volumes and analyzed via Western blot.</p></sec><sec id="s4-15"><title>Western blot analysis</title><p>The assessment of protein levels was performed following a previous study (<xref ref-type="bibr" rid="bib41">Kang et al., 2023</xref>). In brief, Whole cell lysates (WCL) were prepared using radioimmunoprecipitation assay (RIPA) lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 25 mM NaF, 1 mM dithiothreitol (DTT), 20 mM EGTA, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 0.3 mM phenylmethanesulfonyl fluoride (PMSF), and 5 U/mL aprotinin) and the protein concentrations in the lysates were determined using a BioRad protein assay kit (BioRad Laboratories, Hercules, CA). Protein samples were subjected to SDS-PAGE, transferred to a nitrocellulose membrane, and then blocked with 5% bovine serum albumin in TBST for 1 hr at RT. Next, membranes were probed with specific primary antibodies and peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology). The samples were subsequently analyzed using an ECL detection system (Roche Applied Science, Indianapolis, IN). Detection and densitometric analysis were conducted using the iBright Western blot imaging systems (Thermo Fisher).</p></sec><sec id="s4-16"><title>Statistical analysis</title><p>All numeric data are presented as the means ± standard deviation (SD) from at least three independent experiments. Experimental results were analyzed by one-way ANOVA for ranked data followed by Tukey’s honestly significant difference test. The Prism 9 software (GraphPad Software, SanDiego, CA) was used to conduct all statistical analyses. A p-value &lt;0.05 was considered to be statistically significant.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Software, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Software, Validation</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The animal protocol used in this study was approved by the Pusan National University Institutional Animal Care and Use Committee (PNU-IACUC) for ethical procedures and scientific care (Approval Number PNU-2021-0055).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primers for determining levels of gene expression.</title><p>This table provides a comprehensive list of the primers used in this study. For each gene and microRNA, the specific forward and reverse primer sequences are detailed. The sequences are presented in a 5' to 3' direction.</p></caption><media xlink:href="elife-89221-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-89221-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Portions of the original data from this paper have been uploaded to Dryad and are accessible at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.w0vt4b8zt">https://doi.org/10.5061/dryad.w0vt4b8zt</ext-link>. Any information required to utilize and reanalyze the data reported in this paper is available from the corresponding author upon request (bhyoun72@pusan.ac.kr).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Youn</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Data from: PAK3 downregulation induces cognitive impairment following cranial irradiation</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.w0vt4b8zt</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Seo</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>EG</given-names></name><name><surname>Son</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>G</given-names></name><name><surname>Moon</surname><given-names>C</given-names></name><name><surname>Youn</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Gene expression data from the irradiated mouse hippocampus</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE94440">GSE94440</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by a 2-Year Research Grant of Pusan National University.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arendt</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Synaptic degeneration in Alzheimer’s disease</article-title><source>Acta Neuropathologica</source><volume>118</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1007/s00401-009-0536-x</pub-id><pub-id pub-id-type="pmid">19390859</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bączyńska</surname><given-names>E</given-names></name><name><surname>Pels</surname><given-names>KK</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Włodarczyk</surname><given-names>J</given-names></name><name><surname>Ruszczycki</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Quantification of dendritic spines remodeling under physiological stimuli and in pathological conditions</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>4053</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22084053</pub-id><pub-id pub-id-type="pmid">33919977</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baloyannis</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dendritic pathology in Alzheimer’s disease</article-title><source>Journal of the Neurological Sciences</source><volume>283</volume><fpage>153</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2009.02.370</pub-id><pub-id pub-id-type="pmid">19296966</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamburg</surname><given-names>JR</given-names></name><name><surname>Minamide</surname><given-names>LS</given-names></name><name><surname>Wiggan</surname><given-names>O</given-names></name><name><surname>Tahtamouni</surname><given-names>LH</given-names></name><name><surname>Kuhn</surname><given-names>TB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cofilin and actin dynamics: multiple modes of regulation and their Impacts in neuronal development and degeneration</article-title><source>Cells</source><volume>10</volume><elocation-id>2726</elocation-id><pub-id pub-id-type="doi">10.3390/cells10102726</pub-id><pub-id pub-id-type="pmid">34685706</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>KP</given-names></name><name><surname>Nedivi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Spine dynamics: are they all the same?</article-title><source>Neuron</source><volume>96</volume><fpage>43</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.08.008</pub-id><pub-id pub-id-type="pmid">28957675</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>M</given-names></name><name><surname>Castro</surname><given-names>J</given-names></name><name><surname>Saneyoshi</surname><given-names>T</given-names></name><name><surname>Matsuno</surname><given-names>H</given-names></name><name><surname>Sur</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Structural and molecular remodeling of dendritic spine substructures during long-term potentiation</article-title><source>Neuron</source><volume>82</volume><fpage>444</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.03.021</pub-id><pub-id pub-id-type="pmid">24742465</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkman</surname><given-names>TM</given-names></name><name><surname>Krasin</surname><given-names>MJ</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Armstrong</surname><given-names>GT</given-names></name><name><surname>Ojha</surname><given-names>RP</given-names></name><name><surname>Sadighi</surname><given-names>ZS</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Kimberg</surname><given-names>C</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name><name><surname>Merchant</surname><given-names>TE</given-names></name><name><surname>Gajjar</surname><given-names>A</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name><name><surname>Hudson</surname><given-names>MM</given-names></name><name><surname>Krull</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Long-term neurocognitive functioning and social attainment in adult survivors of pediatric CNS tumors: results from the St Jude lifetime cohort study</article-title><source>Journal of Clinical Oncology</source><volume>34</volume><fpage>1358</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1200/JCO.2015.62.2589</pub-id><pub-id pub-id-type="pmid">26834063</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>PD</given-names></name><name><surname>Ahluwalia</surname><given-names>MS</given-names></name><name><surname>Khan</surname><given-names>OH</given-names></name><name><surname>Asher</surname><given-names>AL</given-names></name><name><surname>Wefel</surname><given-names>JS</given-names></name><name><surname>Gondi</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Whole-brain radiotherapy for brain metastases: evolution or revolution?</article-title><source>Journal of Clinical Oncology</source><volume>36</volume><fpage>483</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1200/JCO.2017.75.9589</pub-id><pub-id pub-id-type="pmid">29272161</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceyzériat</surname><given-names>K</given-names></name><name><surname>Zilli</surname><given-names>T</given-names></name><name><surname>Fall</surname><given-names>AB</given-names></name><name><surname>Millet</surname><given-names>P</given-names></name><name><surname>Koutsouvelis</surname><given-names>N</given-names></name><name><surname>Dipasquale</surname><given-names>G</given-names></name><name><surname>Frisoni</surname><given-names>GB</given-names></name><name><surname>Tournier</surname><given-names>BB</given-names></name><name><surname>Garibotto</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Treatment by low-dose brain radiation therapy improves memory performances without changes of the amyloid load in the TgF344-AD rat model</article-title><source>Neurobiology of Aging</source><volume>103</volume><fpage>117</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2021.03.008</pub-id><pub-id pub-id-type="pmid">33895629</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>LY</given-names></name><name><surname>Rex</surname><given-names>CS</given-names></name><name><surname>Casale</surname><given-names>MS</given-names></name><name><surname>Gall</surname><given-names>CM</given-names></name><name><surname>Lynch</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Changes in synaptic morphology accompany actin signaling during LTP</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>5363</fpage><lpage>5372</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0164-07.2007</pub-id><pub-id pub-id-type="pmid">17507558</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>AJ</given-names></name><name><surname>Ott</surname><given-names>T</given-names></name><name><surname>Kepecs</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cognition and the single neuron: How cell types construct the dynamic computations of frontal cortex</article-title><source>Current Opinion in Neurobiology</source><volume>77</volume><elocation-id>102630</elocation-id><pub-id pub-id-type="doi">10.1016/j.conb.2022.102630</pub-id><pub-id pub-id-type="pmid">36209695</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combeau</surname><given-names>G</given-names></name><name><surname>Kreis</surname><given-names>P</given-names></name><name><surname>Domenichini</surname><given-names>F</given-names></name><name><surname>Amar</surname><given-names>M</given-names></name><name><surname>Fossier</surname><given-names>P</given-names></name><name><surname>Rousseau</surname><given-names>V</given-names></name><name><surname>Barnier</surname><given-names>JV</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The p21-activated kinase PAK3 forms heterodimers with PAK1 in brain implementing trans-regulation of PAK3 activity</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>30084</fpage><lpage>30096</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.355073</pub-id><pub-id pub-id-type="pmid">22815483</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conklin</surname><given-names>HM</given-names></name><name><surname>Krull</surname><given-names>KR</given-names></name><name><surname>Reddick</surname><given-names>WE</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Pui</surname><given-names>CH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia</article-title><source>Journal of the National Cancer Institute</source><volume>104</volume><fpage>1386</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.1093/jnci/djs344</pub-id><pub-id pub-id-type="pmid">22927505</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrigan</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>SS</given-names></name><name><surname>Hampton</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings</article-title><source>American Journal of Health-System Pharmacy</source><volume>72</volume><fpage>1544</fpage><lpage>1554</lpage><pub-id pub-id-type="doi">10.2146/ajhp140630</pub-id><pub-id pub-id-type="pmid">26346210</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Counts</surname><given-names>SE</given-names></name><name><surname>Nadeem</surname><given-names>M</given-names></name><name><surname>Lad</surname><given-names>SP</given-names></name><name><surname>Wuu</surname><given-names>J</given-names></name><name><surname>Mufson</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment</article-title><source>Journal of Neuropathology and Experimental Neurology</source><volume>65</volume><fpage>592</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1097/00005072-200606000-00007</pub-id><pub-id pub-id-type="pmid">16783169</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craft</surname><given-names>S</given-names></name><name><surname>Raman</surname><given-names>R</given-names></name><name><surname>Chow</surname><given-names>TW</given-names></name><name><surname>Rafii</surname><given-names>MS</given-names></name><name><surname>Sun</surname><given-names>CK</given-names></name><name><surname>Rissman</surname><given-names>RA</given-names></name><name><surname>Donohue</surname><given-names>MC</given-names></name><name><surname>Brewer</surname><given-names>JB</given-names></name><name><surname>Jenkins</surname><given-names>C</given-names></name><name><surname>Harless</surname><given-names>K</given-names></name><name><surname>Gessert</surname><given-names>D</given-names></name><name><surname>Aisen</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial</article-title><source>JAMA Neurology</source><volume>77</volume><fpage>1099</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2020.1840</pub-id><pub-id pub-id-type="pmid">32568367</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delevich</surname><given-names>K</given-names></name><name><surname>Okada</surname><given-names>NJ</given-names></name><name><surname>Rahane</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Hall</surname><given-names>CD</given-names></name><name><surname>Wilbrecht</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Sex and pubertal status influence dendritic spine density on frontal corticostriatal projection neurons in mice</article-title><source>Cerebral Cortex</source><volume>30</volume><fpage>3543</fpage><lpage>3557</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhz325</pub-id><pub-id pub-id-type="pmid">32037445</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>HB</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>LZ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cranial irradiation induces cognitive decline associated with altered dendritic spine morphology in the young rat hippocampus</article-title><source>Child’s Nervous System</source><volume>38</volume><fpage>1867</fpage><lpage>1875</lpage><pub-id pub-id-type="doi">10.1007/s00381-022-05646-w</pub-id><pub-id pub-id-type="pmid">35962792</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>KM</given-names></name><name><surname>Gallagher</surname><given-names>P</given-names></name><name><surname>Robinson</surname><given-names>LJ</given-names></name><name><surname>Carter</surname><given-names>JD</given-names></name><name><surname>McIntosh</surname><given-names>VV</given-names></name><name><surname>Frampton</surname><given-names>CM</given-names></name><name><surname>Watson</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>AH</given-names></name><name><surname>Ferrier</surname><given-names>IN</given-names></name><name><surname>Porter</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Prevalence of cognitive impairment in major depression and bipolar disorder</article-title><source>Bipolar Disorders</source><volume>20</volume><fpage>260</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1111/bdi.12602</pub-id><pub-id pub-id-type="pmid">29345037</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>DC</given-names></name><name><surname>Sanders</surname><given-names>LC</given-names></name><name><surname>Bokoch</surname><given-names>GM</given-names></name><name><surname>Gill</surname><given-names>GN</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics</article-title><source>Nature Cell Biology</source><volume>1</volume><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1038/12963</pub-id><pub-id pub-id-type="pmid">10559936</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Festa</surname><given-names>LK</given-names></name><name><surname>Irollo</surname><given-names>E</given-names></name><name><surname>Platt</surname><given-names>BJ</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Floresco</surname><given-names>S</given-names></name><name><surname>Meucci</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility</article-title><source>eLife</source><volume>9</volume><elocation-id>e49717</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.49717</pub-id><pub-id pub-id-type="pmid">31971513</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortuna</surname><given-names>A</given-names></name><name><surname>Alves</surname><given-names>G</given-names></name><name><surname>Serralheiro</surname><given-names>A</given-names></name><name><surname>Sousa</surname><given-names>J</given-names></name><name><surname>Falcão</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules</article-title><source>European Journal of Pharmaceutics and Biopharmaceutics</source><volume>88</volume><fpage>8</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2014.03.004</pub-id><pub-id pub-id-type="pmid">24681294</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchsova</surname><given-names>B</given-names></name><name><surname>Alvarez Juliá</surname><given-names>A</given-names></name><name><surname>Rizavi</surname><given-names>HS</given-names></name><name><surname>Frasch</surname><given-names>AC</given-names></name><name><surname>Pandey</surname><given-names>GN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression</article-title><source>Neuroscience</source><volume>333</volume><fpage>331</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.07.037</pub-id><pub-id pub-id-type="pmid">27474226</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furubayashi</surname><given-names>T</given-names></name><name><surname>Kamaguchi</surname><given-names>A</given-names></name><name><surname>Kawaharada</surname><given-names>K</given-names></name><name><surname>Masaoka</surname><given-names>Y</given-names></name><name><surname>Kataoka</surname><given-names>M</given-names></name><name><surname>Yamashita</surname><given-names>S</given-names></name><name><surname>Higashi</surname><given-names>Y</given-names></name><name><surname>Sakane</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats</article-title><source>Biological &amp; Pharmaceutical Bulletin</source><volume>30</volume><fpage>608</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1248/bpb.30.608</pub-id><pub-id pub-id-type="pmid">17329868</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebreegziabhere</surname><given-names>Y</given-names></name><name><surname>Habatmu</surname><given-names>K</given-names></name><name><surname>Mihretu</surname><given-names>A</given-names></name><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Alem</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cognitive impairment in people with schizophrenia: an umbrella review</article-title><source>European Archives of Psychiatry and Clinical Neuroscience</source><volume>272</volume><fpage>1139</fpage><lpage>1155</lpage><pub-id pub-id-type="doi">10.1007/s00406-022-01416-6</pub-id><pub-id pub-id-type="pmid">35633394</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greene-Schloesser</surname><given-names>D</given-names></name><name><surname>Moore</surname><given-names>E</given-names></name><name><surname>Robbins</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Molecular pathways: radiation-induced cognitive impairment</article-title><source>Clinical Cancer Research</source><volume>19</volume><fpage>2294</fpage><lpage>2300</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-2903</pub-id><pub-id pub-id-type="pmid">23388505</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>DW</given-names></name><name><surname>Ji</surname><given-names>CH</given-names></name><name><surname>Wang</surname><given-names>CN</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>WQ</given-names></name><name><surname>Gu</surname><given-names>JH</given-names></name><name><surname>Chen</surname><given-names>YM</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>JF</given-names></name><name><surname>Jiang</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Hippocampal miR-206-3p participates in the pathogenesis of depression via regulating the expression of BDNF</article-title><source>Pharmacological Research</source><volume>174</volume><elocation-id>105932</elocation-id><pub-id pub-id-type="doi">10.1016/j.phrs.2021.105932</pub-id><pub-id pub-id-type="pmid">34628001</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Domains of cognition and their assessment</article-title><source>Dialogues in Clinical Neuroscience</source><volume>21</volume><fpage>227</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.31887/DCNS.2019.21.3/pharvey</pub-id><pub-id pub-id-type="pmid">31749647</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hering</surname><given-names>H</given-names></name><name><surname>Sheng</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Dendritic spines: structure, dynamics and regulation</article-title><source>Nature Reviews Neuroscience</source><volume>2</volume><fpage>880</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1038/35104061</pub-id><pub-id pub-id-type="pmid">11733795</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilgenberg</surname><given-names>LGW</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Preparation of dissociated mouse cortical neuron cultures</article-title><source>Journal of Visualized Experiments</source><elocation-id>562</elocation-id><pub-id pub-id-type="doi">10.3791/562</pub-id><pub-id pub-id-type="pmid">18989405</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hlushchenko</surname><given-names>I</given-names></name><name><surname>Koskinen</surname><given-names>M</given-names></name><name><surname>Hotulainen</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dendritic spine actin dynamics in neuronal maturation and synaptic plasticity</article-title><source>Cytoskeleton</source><volume>73</volume><fpage>435</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1002/cm.21280</pub-id><pub-id pub-id-type="pmid">26849484</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogeveen</surname><given-names>J</given-names></name><name><surname>Medalla</surname><given-names>M</given-names></name><name><surname>Ainsworth</surname><given-names>M</given-names></name><name><surname>Galeazzi</surname><given-names>JM</given-names></name><name><surname>Hanlon</surname><given-names>CA</given-names></name><name><surname>Mansouri</surname><given-names>FA</given-names></name><name><surname>Costa</surname><given-names>VD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>What does the frontopolar cortex contribute to goal-directed cognition and action?</article-title><source>The Journal of Neuroscience</source><volume>42</volume><fpage>8508</fpage><lpage>8513</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1143-22.2022</pub-id><pub-id pub-id-type="pmid">36351824</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hölter</surname><given-names>SM</given-names></name><name><surname>Garrett</surname><given-names>L</given-names></name><name><surname>Einicke</surname><given-names>J</given-names></name><name><surname>Sperling</surname><given-names>B</given-names></name><name><surname>Dirscherl</surname><given-names>P</given-names></name><name><surname>Zimprich</surname><given-names>A</given-names></name><name><surname>Fuchs</surname><given-names>H</given-names></name><name><surname>Gailus-Durner</surname><given-names>V</given-names></name><name><surname>Hrabě de Angelis</surname><given-names>M</given-names></name><name><surname>Wurst</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Assessing cognition in mice</article-title><source>Current Protocols in Mouse Biology</source><volume>5</volume><fpage>331</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1002/9780470942390.mo150068</pub-id><pub-id pub-id-type="pmid">26629775</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houillier</surname><given-names>C</given-names></name><name><surname>Taillandier</surname><given-names>L</given-names></name><name><surname>Dureau</surname><given-names>S</given-names></name><name><surname>Lamy</surname><given-names>T</given-names></name><name><surname>Laadhari</surname><given-names>M</given-names></name><name><surname>Chinot</surname><given-names>O</given-names></name><name><surname>Moluçon-Chabrot</surname><given-names>C</given-names></name><name><surname>Soubeyran</surname><given-names>P</given-names></name><name><surname>Gressin</surname><given-names>R</given-names></name><name><surname>Choquet</surname><given-names>S</given-names></name><name><surname>Damaj</surname><given-names>G</given-names></name><name><surname>Thyss</surname><given-names>A</given-names></name><name><surname>Abraham</surname><given-names>J</given-names></name><name><surname>Delwail</surname><given-names>V</given-names></name><name><surname>Gyan</surname><given-names>E</given-names></name><name><surname>Sanhes</surname><given-names>L</given-names></name><name><surname>Cornillon</surname><given-names>J</given-names></name><name><surname>Garidi</surname><given-names>R</given-names></name><name><surname>Delmer</surname><given-names>A</given-names></name><name><surname>Tanguy</surname><given-names>ML</given-names></name><name><surname>Al Jijakli</surname><given-names>A</given-names></name><name><surname>Morel</surname><given-names>P</given-names></name><name><surname>Bourquard</surname><given-names>P</given-names></name><name><surname>Moles</surname><given-names>MP</given-names></name><name><surname>Chauchet</surname><given-names>A</given-names></name><name><surname>Gastinne</surname><given-names>T</given-names></name><name><surname>Constans</surname><given-names>JM</given-names></name><name><surname>Langer</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Moisson</surname><given-names>P</given-names></name><name><surname>Lacomblez</surname><given-names>L</given-names></name><name><surname>Martin-Duverneuil</surname><given-names>N</given-names></name><name><surname>Delgadillo</surname><given-names>D</given-names></name><name><surname>Turbiez</surname><given-names>I</given-names></name><name><surname>Feuvret</surname><given-names>L</given-names></name><name><surname>Cassoux</surname><given-names>N</given-names></name><name><surname>Touitou</surname><given-names>V</given-names></name><name><surname>Ricard</surname><given-names>D</given-names></name><name><surname>Hoang-Xuan</surname><given-names>K</given-names></name><name><surname>Soussain</surname><given-names>C</given-names></name><collab>Intergroupe GOELAMS–ANOCEF and the LOC Network for CNS Lymphoma</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the intergroup ANOCEF-GOELAMS randomized phase II PRECIS study</article-title><source>Journal of Clinical Oncology</source><volume>37</volume><fpage>823</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1200/JCO.18.00306</pub-id><pub-id pub-id-type="pmid">30785830</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Lafaille</surname><given-names>JJ</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Learning-dependent dendritic spine plasticity is impaired in spontaneous autoimmune encephalomyelitis</article-title><source>Developmental Neurobiology</source><volume>81</volume><fpage>736</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1002/dneu.22827</pub-id><pub-id pub-id-type="pmid">33949123</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>NK</given-names></name><name><surname>Thomas</surname><given-names>GM</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Regulation of AMPA receptor subunit GluA1 surface expression by PAK3 phosphorylation</article-title><source>PNAS</source><volume>112</volume><fpage>E5883</fpage><lpage>E5890</lpage><pub-id pub-id-type="doi">10.1073/pnas.1518382112</pub-id><pub-id pub-id-type="pmid">26460013</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jauhar</surname><given-names>S</given-names></name><name><surname>Johnstone</surname><given-names>M</given-names></name><name><surname>McKenna</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Schizophrenia</article-title><source>Lancet</source><volume>399</volume><fpage>473</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)01730-X</pub-id><pub-id pub-id-type="pmid">35093231</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jessen</surname><given-names>F</given-names></name><name><surname>Amariglio</surname><given-names>RE</given-names></name><name><surname>Buckley</surname><given-names>RF</given-names></name><name><surname>van der Flier</surname><given-names>WM</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Molinuevo</surname><given-names>JL</given-names></name><name><surname>Rabin</surname><given-names>L</given-names></name><name><surname>Rentz</surname><given-names>DM</given-names></name><name><surname>Rodriguez-Gomez</surname><given-names>O</given-names></name><name><surname>Saykin</surname><given-names>AJ</given-names></name><name><surname>Sikkes</surname><given-names>SAM</given-names></name><name><surname>Smart</surname><given-names>CM</given-names></name><name><surname>Wolfsgruber</surname><given-names>S</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The characterisation of subjective cognitive decline</article-title><source>The Lancet Neurology</source><volume>19</volume><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(19)30368-0</pub-id><pub-id pub-id-type="pmid">31958406</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandimalla</surname><given-names>R</given-names></name><name><surname>Manczak</surname><given-names>M</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Reddy</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer’s disease</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>30</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx381</pub-id><pub-id pub-id-type="pmid">29040533</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Seo</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Son</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>G</given-names></name><name><surname>Jo</surname><given-names>S</given-names></name><name><surname>Moon</surname><given-names>C</given-names></name><name><surname>Youn</surname><given-names>H</given-names></name><name><surname>Youn</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Radiation-induced overexpression of transthyretin inhibits retinol-mediated hippocampal neurogenesis</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>8394</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-26762-1</pub-id><pub-id pub-id-type="pmid">29849106</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Shin</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Youn</surname><given-names>H</given-names></name><name><surname>Youn</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma</article-title><source>Cell Reports. Medicine</source><volume>4</volume><elocation-id>100880</elocation-id><pub-id pub-id-type="doi">10.1016/j.xcrm.2022.100880</pub-id><pub-id pub-id-type="pmid">36603576</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Biag</surname><given-names>J</given-names></name><name><surname>Fass</surname><given-names>DM</given-names></name><name><surname>Lewis</surname><given-names>MC</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Fleishman</surname><given-names>M</given-names></name><name><surname>Gangwar</surname><given-names>SP</given-names></name><name><surname>Machius</surname><given-names>M</given-names></name><name><surname>Fromer</surname><given-names>M</given-names></name><name><surname>Purcell</surname><given-names>SM</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Rudenko</surname><given-names>G</given-names></name><name><surname>Premont</surname><given-names>RT</given-names></name><name><surname>Scolnick</surname><given-names>EM</given-names></name><name><surname>Haggarty</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity</article-title><source>Molecular Psychiatry</source><volume>22</volume><fpage>417</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1038/mp.2016.98</pub-id><pub-id pub-id-type="pmid">27457813</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Shin</surname><given-names>E</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Jeon</surname><given-names>J</given-names></name><name><surname>Youn</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Baiap3 regulates depressive behaviors in mice via attenuating dense core vesicle trafficking in subsets of prefrontal cortex neurons</article-title><source>Neurobiology of Stress</source><volume>16</volume><elocation-id>100423</elocation-id><pub-id pub-id-type="doi">10.1016/j.ynstr.2021.100423</pub-id><pub-id pub-id-type="pmid">35028340</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraeuter</surname><given-names>AK</given-names></name><name><surname>Guest</surname><given-names>PC</given-names></name><name><surname>Sarnyai</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The Y-maze for assessment of spatial working and reference memory in mice</article-title><source>Methods in Molecular Biology</source><volume>1916</volume><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-8994-2_10</pub-id><pub-id pub-id-type="pmid">30535688</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krull</surname><given-names>KR</given-names></name><name><surname>Brinkman</surname><given-names>TM</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Armstrong</surname><given-names>GT</given-names></name><name><surname>Ness</surname><given-names>KK</given-names></name><name><surname>Srivastava</surname><given-names>DK</given-names></name><name><surname>Gurney</surname><given-names>JG</given-names></name><name><surname>Kimberg</surname><given-names>C</given-names></name><name><surname>Krasin</surname><given-names>MJ</given-names></name><name><surname>Pui</surname><given-names>CH</given-names></name><name><surname>Robison</surname><given-names>LL</given-names></name><name><surname>Hudson</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study</article-title><source>Journal of Clinical Oncology</source><volume>31</volume><fpage>4407</fpage><lpage>4415</lpage><pub-id pub-id-type="doi">10.1200/JCO.2012.48.2315</pub-id><pub-id pub-id-type="pmid">24190124</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krull</surname><given-names>KR</given-names></name><name><surname>Hardy</surname><given-names>KK</given-names></name><name><surname>Kahalley</surname><given-names>LS</given-names></name><name><surname>Schuitema</surname><given-names>I</given-names></name><name><surname>Kesler</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neurocognitive outcomes and interventions in long-term survivors of childhood cancer</article-title><source>Journal of Clinical Oncology</source><volume>36</volume><fpage>2181</fpage><lpage>2189</lpage><pub-id pub-id-type="doi">10.1200/JCO.2017.76.4696</pub-id><pub-id pub-id-type="pmid">29874137</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamprecht</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Actin cytoskeleton role in the maintenance of neuronal mMorphology and long-term memory</article-title><source>Cells</source><volume>10</volume><elocation-id>1795</elocation-id><pub-id pub-id-type="doi">10.3390/cells10071795</pub-id><pub-id pub-id-type="pmid">34359964</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauterborn</surname><given-names>JC</given-names></name><name><surname>Cox</surname><given-names>CD</given-names></name><name><surname>Chan</surname><given-names>SW</given-names></name><name><surname>Vanderklish</surname><given-names>PW</given-names></name><name><surname>Lynch</surname><given-names>G</given-names></name><name><surname>Gall</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Synaptic actin stabilization protein loss in down syndrome and Alzheimer disease</article-title><source>Brain Pathology</source><volume>30</volume><fpage>319</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1111/bpa.12779</pub-id><pub-id pub-id-type="pmid">31410926</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>A</given-names></name><name><surname>Snyder</surname><given-names>W</given-names></name><name><surname>Peeples</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Intranasal administration of extracellular vesicles mitigates apoptosis in a mouse model of neonatal hypoxic-Ischemic brain injury</article-title><source>Neonatology</source><volume>119</volume><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1159/000522644</pub-id><pub-id pub-id-type="pmid">35340004</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>W</given-names></name><name><surname>Omotade</surname><given-names>OF</given-names></name><name><surname>Myers</surname><given-names>KR</given-names></name><name><surname>Zheng</surname><given-names>JQ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Actin cytoskeleton in dendritic spine development and plasticity</article-title><source>Current Opinion in Neurobiology</source><volume>39</volume><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2016.04.010</pub-id><pub-id pub-id-type="pmid">27138585</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The role of p21-activated kinases in cancer and beyond: Where are we heading?</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>641381</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.641381</pub-id><pub-id pub-id-type="pmid">33796531</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mai</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>T</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Wan</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>B</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Intranasal administration of miR-146a agomir rescued the pathological process and cognitive impairment in an AD mouse model</article-title><source>Molecular Therapy Nucleic Acids</source><volume>18</volume><fpage>681</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1016/j.omtn.2019.10.002</pub-id><pub-id pub-id-type="pmid">31707205</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makale</surname><given-names>MT</given-names></name><name><surname>McDonald</surname><given-names>CR</given-names></name><name><surname>Hattangadi-Gluth</surname><given-names>JA</given-names></name><name><surname>Kesari</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours</article-title><source>Nature Reviews Neurology</source><volume>13</volume><fpage>52</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2016.185</pub-id><pub-id pub-id-type="pmid">27982041</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>J</given-names></name><name><surname>Meng</surname><given-names>Y</given-names></name><name><surname>Hanna</surname><given-names>A</given-names></name><name><surname>Janus</surname><given-names>C</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3</article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>6641</fpage><lpage>6650</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0028-05.2005</pub-id><pub-id pub-id-type="pmid">16014725</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mistry</surname><given-names>A</given-names></name><name><surname>Stolnik</surname><given-names>S</given-names></name><name><surname>Illum</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nanoparticles for direct nose-to-brain delivery of drugs</article-title><source>International Journal of Pharmaceutics</source><volume>379</volume><fpage>146</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2009.06.019</pub-id><pub-id pub-id-type="pmid">19555750</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molli</surname><given-names>PR</given-names></name><name><surname>Li</surname><given-names>DQ</given-names></name><name><surname>Murray</surname><given-names>BW</given-names></name><name><surname>Rayala</surname><given-names>SK</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>PAK signaling in oncogenesis</article-title><source>Oncogene</source><volume>28</volume><fpage>2545</fpage><lpage>2555</lpage><pub-id pub-id-type="doi">10.1038/onc.2009.119</pub-id><pub-id pub-id-type="pmid">19465939</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname><given-names>EM</given-names></name><name><surname>Kane</surname><given-names>A</given-names></name><name><surname>Goff</surname><given-names>DC</given-names></name><name><surname>Walsh</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment</article-title><source>Schizophrenia Research</source><volume>106</volume><fpage>265</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.schres.2008.08.021</pub-id><pub-id pub-id-type="pmid">18805672</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakahata</surname><given-names>Y</given-names></name><name><surname>Yasuda</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Plasticity of spine structure: local signaling, translation and cytoskeletal reorganization</article-title><source>Frontiers in Synaptic Neuroscience</source><volume>10</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.3389/fnsyn.2018.00029</pub-id><pub-id pub-id-type="pmid">30210329</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owonikoko</surname><given-names>TK</given-names></name><name><surname>Arbiser</surname><given-names>J</given-names></name><name><surname>Zelnak</surname><given-names>A</given-names></name><name><surname>Shu</surname><given-names>HKG</given-names></name><name><surname>Shim</surname><given-names>H</given-names></name><name><surname>Robin</surname><given-names>AM</given-names></name><name><surname>Kalkanis</surname><given-names>SN</given-names></name><name><surname>Whitsett</surname><given-names>TG</given-names></name><name><surname>Salhia</surname><given-names>B</given-names></name><name><surname>Tran</surname><given-names>NL</given-names></name><name><surname>Ryken</surname><given-names>T</given-names></name><name><surname>Moore</surname><given-names>MK</given-names></name><name><surname>Egan</surname><given-names>KM</given-names></name><name><surname>Olson</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Current approaches to the treatment of metastatic brain tumours</article-title><source>Nature Reviews Clinical Oncology</source><volume>11</volume><fpage>203</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2014.25</pub-id><pub-id pub-id-type="pmid">24569448</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pazzaglia</surname><given-names>S</given-names></name><name><surname>Briganti</surname><given-names>G</given-names></name><name><surname>Mancuso</surname><given-names>M</given-names></name><name><surname>Saran</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neurocognitive decline following radiotherapy: mechanisms and therapeutic implications</article-title><source>Cancers</source><volume>12</volume><elocation-id>146</elocation-id><pub-id pub-id-type="doi">10.3390/cancers12010146</pub-id><pub-id pub-id-type="pmid">31936195</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>RB</given-names></name><name><surname>Duman</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model</article-title><source>Molecular Psychiatry</source><volume>25</volume><fpage>530</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1038/s41380-019-0615-x</pub-id><pub-id pub-id-type="pmid">31801966</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintana</surname><given-names>DS</given-names></name><name><surname>Guastella</surname><given-names>AJ</given-names></name><name><surname>Westlye</surname><given-names>LT</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders</article-title><source>Molecular Psychiatry</source><volume>21</volume><fpage>29</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1038/mp.2015.166</pub-id><pub-id pub-id-type="pmid">26552590</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raber</surname><given-names>J</given-names></name><name><surname>Rola</surname><given-names>R</given-names></name><name><surname>LeFevour</surname><given-names>A</given-names></name><name><surname>Morhardt</surname><given-names>D</given-names></name><name><surname>Curley</surname><given-names>J</given-names></name><name><surname>Mizumatsu</surname><given-names>S</given-names></name><name><surname>VandenBerg</surname><given-names>SR</given-names></name><name><surname>Fike</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis</article-title><source>Radiation Research</source><volume>162</volume><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1667/rr3206</pub-id><pub-id pub-id-type="pmid">15222778</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rane</surname><given-names>CK</given-names></name><name><surname>Minden</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>P21 activated kinases: structure, regulation, and functions</article-title><source>Small GTPases</source><volume>5</volume><elocation-id>e28003</elocation-id><pub-id pub-id-type="doi">10.4161/sgtp.28003</pub-id><pub-id pub-id-type="pmid">24658305</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapp</surname><given-names>SR</given-names></name><name><surname>Case</surname><given-names>LD</given-names></name><name><surname>Peiffer</surname><given-names>A</given-names></name><name><surname>Naughton</surname><given-names>MM</given-names></name><name><surname>Chan</surname><given-names>MD</given-names></name><name><surname>Stieber</surname><given-names>VW</given-names></name><name><surname>Moore</surname><given-names>DF</given-names></name><name><surname>Falchuk</surname><given-names>SC</given-names></name><name><surname>Piephoff</surname><given-names>JV</given-names></name><name><surname>Edenfield</surname><given-names>WJ</given-names></name><name><surname>Giguere</surname><given-names>JK</given-names></name><name><surname>Loghin</surname><given-names>ME</given-names></name><name><surname>Shaw</surname><given-names>EG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Donepezil for irradiated brain tumor Survivors: a Phase III randomized placebo-controlled clinical trial</article-title><source>Journal of Clinical Oncology</source><volume>33</volume><fpage>1653</fpage><lpage>1659</lpage><pub-id pub-id-type="doi">10.1200/JCO.2014.58.4508</pub-id><pub-id pub-id-type="pmid">25897156</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rex</surname><given-names>CS</given-names></name><name><surname>Chen</surname><given-names>LY</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Babayan</surname><given-names>AH</given-names></name><name><surname>Gall</surname><given-names>CM</given-names></name><name><surname>Lynch</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation</article-title><source>The Journal of Cell Biology</source><volume>186</volume><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1083/jcb.200901084</pub-id><pub-id pub-id-type="pmid">19596849</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosi</surname><given-names>S</given-names></name><name><surname>Andres-Mach</surname><given-names>M</given-names></name><name><surname>Fishman</surname><given-names>KM</given-names></name><name><surname>Levy</surname><given-names>W</given-names></name><name><surname>Ferguson</surname><given-names>RA</given-names></name><name><surname>Fike</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cranial irradiation alters the behaviorally induced immediate-early gene arc (activity-regulated cytoskeleton-associated protein)</article-title><source>Cancer Research</source><volume>68</volume><fpage>9763</fpage><lpage>9770</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-1861</pub-id><pub-id pub-id-type="pmid">19047155</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rungratanawanich</surname><given-names>W</given-names></name><name><surname>Cenini</surname><given-names>G</given-names></name><name><surname>Mastinu</surname><given-names>A</given-names></name><name><surname>Sylvester</surname><given-names>M</given-names></name><name><surname>Wilkening</surname><given-names>A</given-names></name><name><surname>Abate</surname><given-names>G</given-names></name><name><surname>Bonini</surname><given-names>SA</given-names></name><name><surname>Aria</surname><given-names>F</given-names></name><name><surname>Marziano</surname><given-names>M</given-names></name><name><surname>Maccarinelli</surname><given-names>G</given-names></name><name><surname>Memo</surname><given-names>M</given-names></name><name><surname>Voos</surname><given-names>W</given-names></name><name><surname>Uberti</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>γ-Oryzanol Improves cognitive function and modulates hippocampal proteome in mice</article-title><source>Nutrients</source><volume>11</volume><elocation-id>753</elocation-id><pub-id pub-id-type="doi">10.3390/nu11040753</pub-id><pub-id pub-id-type="pmid">30935111</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakimoto</surname><given-names>Y</given-names></name><name><surname>Oo</surname><given-names>PMT</given-names></name><name><surname>Goshima</surname><given-names>M</given-names></name><name><surname>Kanehisa</surname><given-names>I</given-names></name><name><surname>Tsukada</surname><given-names>Y</given-names></name><name><surname>Mitsushima</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Significance of GABA<sub>A</sub> Receptor for cognitive function and hippocampal pathology</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>12456</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222212456</pub-id><pub-id pub-id-type="pmid">34830337</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>SS</given-names></name><name><surname>Dellarole</surname><given-names>A</given-names></name><name><surname>Peterson</surname><given-names>EC</given-names></name><name><surname>Bregy</surname><given-names>A</given-names></name><name><surname>Komotar</surname><given-names>R</given-names></name><name><surname>Harvey</surname><given-names>PD</given-names></name><name><surname>Elhammady</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Long-term psychiatric outcomes in pediatric brain tumor survivors</article-title><source>Child’s Nervous System</source><volume>31</volume><fpage>653</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1007/s00381-015-2669-7</pub-id><pub-id pub-id-type="pmid">25726165</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>EY</given-names></name><name><surname>Lee</surname><given-names>CS</given-names></name><name><surname>Cho</surname><given-names>TG</given-names></name><name><surname>Kim</surname><given-names>YG</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Juhnn</surname><given-names>YS</given-names></name><name><surname>Park</surname><given-names>SC</given-names></name><name><surname>Manser</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>EG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>betaPak-interacting exchange factor-mediated Rac1 activation requires smgGDS guanine nucleotide exchange factor in basic fibroblast growth factor-induced neurite outgrowth</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>35954</fpage><lpage>35964</lpage><pub-id pub-id-type="doi">10.1074/jbc.M602399200</pub-id><pub-id pub-id-type="pmid">16954223</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>E</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Jeon</surname><given-names>J</given-names></name><name><surname>Seong</surname><given-names>K</given-names></name><name><surname>Youn</surname><given-names>H</given-names></name><name><surname>Youn</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Exosomal Plasminogen activator inhibitor-1 induces ionizing radiation-adaptive glioblastoma cachexia</article-title><source>Cells</source><volume>11</volume><elocation-id>3102</elocation-id><pub-id pub-id-type="doi">10.3390/cells11193102</pub-id><pub-id pub-id-type="pmid">36231065</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slotman</surname><given-names>B</given-names></name><name><surname>Faivre-Finn</surname><given-names>C</given-names></name><name><surname>Kramer</surname><given-names>G</given-names></name><name><surname>Rankin</surname><given-names>E</given-names></name><name><surname>Snee</surname><given-names>M</given-names></name><name><surname>Hatton</surname><given-names>M</given-names></name><name><surname>Postmus</surname><given-names>P</given-names></name><name><surname>Collette</surname><given-names>L</given-names></name><name><surname>Musat</surname><given-names>E</given-names></name><name><surname>Senan</surname><given-names>S</given-names></name><collab>EORTC Radiation Oncology Group and Lung Cancer Group</collab></person-group><year iso-8601-date="2007">2007</year><article-title>Prophylactic cranial irradiation in extensive small-cell lung cancer</article-title><source>The New England Journal of Medicine</source><volume>357</volume><fpage>664</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa071780</pub-id><pub-id pub-id-type="pmid">17699816</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>KR</given-names></name><name><surname>Davenport</surname><given-names>EC</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Pathania</surname><given-names>M</given-names></name><name><surname>Vaccaro</surname><given-names>V</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Kittler</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>GIT1 and βPIX are essential for GABA(A) receptor synaptic stability and inhibitory neurotransmission</article-title><source>Cell Reports</source><volume>9</volume><fpage>298</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.08.061</pub-id><pub-id pub-id-type="pmid">25284783</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Spijker</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><chapter-title>Dissection of rodent brain regions</chapter-title><person-group person-group-type="editor"><name><surname>Li</surname><given-names>KW</given-names></name></person-group><source>Neuroproteomics</source><publisher-name>Humana Press</publisher-name><fpage>13</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-111-6</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suwinski</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Prophylactic cranial irradiation in SCLC</article-title><source>Translational Lung Cancer Research</source><volume>10</volume><fpage>2071</fpage><lpage>2078</lpage><pub-id pub-id-type="doi">10.21037/tlcr-2020-rtm-05</pub-id><pub-id pub-id-type="pmid">34012815</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szatmari</surname><given-names>EM</given-names></name><name><surname>Moran</surname><given-names>C</given-names></name><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Jacob</surname><given-names>A</given-names></name><name><surname>Parra-Bueno</surname><given-names>P</given-names></name><name><surname>Kamasawa</surname><given-names>N</given-names></name><name><surname>Guerrero-Given</surname><given-names>D</given-names></name><name><surname>Klein</surname><given-names>M</given-names></name><name><surname>Stackman</surname><given-names>R</given-names></name><name><surname>Yasuda</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ADAP1/Centaurin-α1 negatively regulates dendritic spine function and memory formation in the hippocampus</article-title><source>eNeuro</source><volume>8</volume><elocation-id>ENEURO.0111-20.2020</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0111-20.2020</pub-id><pub-id pub-id-type="pmid">33139322</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thévenot</surname><given-names>E</given-names></name><name><surname>Moreau</surname><given-names>AW</given-names></name><name><surname>Rousseau</surname><given-names>V</given-names></name><name><surname>Combeau</surname><given-names>G</given-names></name><name><surname>Domenichini</surname><given-names>F</given-names></name><name><surname>Jacquet</surname><given-names>C</given-names></name><name><surname>Goupille</surname><given-names>O</given-names></name><name><surname>Amar</surname><given-names>M</given-names></name><name><surname>Kreis</surname><given-names>P</given-names></name><name><surname>Fossier</surname><given-names>P</given-names></name><name><surname>Barnier</surname><given-names>JV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>p21-Activated kinase 3 (PAK3) protein regulates synaptic transmission through its interaction with the Nck2/Grb4 protein adaptor</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>40044</fpage><lpage>40059</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.262246</pub-id><pub-id pub-id-type="pmid">21949127</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname><given-names>C</given-names></name><name><surname>Tucker</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Intranasal route as an alternative method of medication administration</article-title><source>Critical Care Nurse</source><volume>38</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.4037/ccn2018836</pub-id><pub-id pub-id-type="pmid">30275061</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegner</surname><given-names>RE</given-names></name><name><surname>Abel</surname><given-names>S</given-names></name><name><surname>Horne</surname><given-names>ZD</given-names></name><name><surname>Hasan</surname><given-names>S</given-names></name><name><surname>Verma</surname><given-names>V</given-names></name><name><surname>Ranjan</surname><given-names>T</given-names></name><name><surname>Williamson</surname><given-names>RW</given-names></name><name><surname>Karlovits</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>National trends in radiation dose escalation for glioblastoma</article-title><source>Radiation Oncology Journal</source><volume>37</volume><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.3857/roj.2019.00017</pub-id><pub-id pub-id-type="pmid">30947476</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Depression and cognitive impairment: current understanding of its neurobiology and diagnosis</article-title><source>Neuropsychiatric Disease and Treatment</source><volume>18</volume><fpage>2783</fpage><lpage>2794</lpage><pub-id pub-id-type="doi">10.2147/NDT.S383093</pub-id><pub-id pub-id-type="pmid">36471744</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>GD</given-names></name><name><surname>Wilson</surname><given-names>TG</given-names></name><name><surname>Hanna</surname><given-names>A</given-names></name><name><surname>Fontanesi</surname><given-names>G</given-names></name><name><surname>Kulchycki</surname><given-names>J</given-names></name><name><surname>Buelow</surname><given-names>K</given-names></name><name><surname>Pruetz</surname><given-names>BL</given-names></name><name><surname>Michael</surname><given-names>DB</given-names></name><name><surname>Chinnaiyan</surname><given-names>P</given-names></name><name><surname>Maddens</surname><given-names>ME</given-names></name><name><surname>Martinez</surname><given-names>AA</given-names></name><name><surname>Fontanesi</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Low dose brain irradiation reduces amyloid-β and tau in 3xTg-AD mice</article-title><source>Journal of Alzheimer’s Disease</source><volume>75</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.3233/JAD-200030</pub-id><pub-id pub-id-type="pmid">32280098</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>p21-Activated kinases as promising therapeutic targets in hematological malignancies</article-title><source>Leukemia</source><volume>36</volume><fpage>315</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1038/s41375-021-01451-7</pub-id><pub-id pub-id-type="pmid">34697424</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>S</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Prophylactic cranial Irradiation for extensive-stage small-cell lung cancer: a controversial area</article-title><source>Frontiers in Oncology</source><volume>12</volume><elocation-id>772282</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2022.772282</pub-id><pub-id pub-id-type="pmid">35198438</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Zimmermann</surname><given-names>HR</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Brain-specific suppression of AMPKα2 isoform impairs cognition and hippocampal LTP by PERK-mediated eIF2α phosphorylation</article-title><source>Molecular Psychiatry</source><volume>26</volume><fpage>1880</fpage><lpage>1897</lpage><pub-id pub-id-type="doi">10.1038/s41380-020-0739-z</pub-id><pub-id pub-id-type="pmid">32366952</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Webb</surname><given-names>DJ</given-names></name><name><surname>Asmussen</surname><given-names>H</given-names></name><name><surname>Niu</surname><given-names>S</given-names></name><name><surname>Horwitz</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC</article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>3379</fpage><lpage>3388</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3553-04.2005</pub-id><pub-id pub-id-type="pmid">15800193</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Lam</surname><given-names>TT</given-names></name><name><surname>Weng</surname><given-names>C</given-names></name><name><surname>Bronk</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Duman</surname><given-names>JG</given-names></name><name><surname>Dougherty</surname><given-names>PM</given-names></name><name><surname>Grosshans</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Radiation induces age-dependent deficits in cortical synaptic plasticity</article-title><source>Neuro-Oncology</source><volume>20</volume><fpage>1207</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1093/neuonc/noy052</pub-id><pub-id pub-id-type="pmid">29660023</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Semiautomated and automated quantitative analysis of corneal sub-basal nerves in patients with DED with ocular pain using IVCM</article-title><source>Frontiers in Medicine</source><volume>9</volume><elocation-id>831307</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2022.831307</pub-id><pub-id pub-id-type="pmid">35223926</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Ou</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>W</given-names></name><name><surname>Xing</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>C</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Prior nasal delivery of antagomiR-122 prevents radiation-induced brain injury</article-title><source>Molecular Therapy</source><volume>29</volume><fpage>3465</fpage><lpage>3483</lpage><pub-id pub-id-type="doi">10.1016/j.ymthe.2021.06.019</pub-id><pub-id pub-id-type="pmid">34174438</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89221.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Keqiang</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>Chinese Academy of Sciences</institution></institution-wrap><country>China</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Useful</kwd></kwd-group></front-stub><body><p>The study investigates the functional impact of cranial irradiation in mouse and proposes PAK3 as molecular element involved in radiation-induced cognitive decrement. The significance of the findings is <bold>useful</bold> for fields covering radiation, brain tumor and cognition. The strength of evidence is <bold>solid</bold>, although the referees expressed divergent views on the manuscript.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89221.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Exposure to cranial irradiation (IR) leads to cognitive deficits in the survivors of brain cancer. IR upregulates miR-206-3p, which in turn reduces the PAK3-LIMK1 axis leading to the loss of F and G-actin ratio and, thereby, mature dendritic spine loss. Silencing miR-206-3p reverses these degenerative consequences.</p><p>Strengths:</p><p>The authors show compelling data indicating a clear correlation between PAK3 knockdown and the loss of mature dendritic spine density. In contrast, overexpression of PAK3 in the irradiated neurons restored mature spine types and recovered the F/G ratio. These in vitro results support the authors' hypotheses that PAK3 and LIMK1-mediated downstream signaling impact neuronal structure and reorganization in vitro. These data were supported by similar experiments using differentiated human neurons. Importantly, silencing miR-206-30 using antagonist miR also reverses IR-induced downregulation of the PAK3-LIMK1 axis, preventing spine loss and cognitive deficits.</p><p>Weaknesses:</p><p>All the miR-206-3p data are presented from in vitro cortical neurons or human stem cell-derived neuron cultures. This data (IR-induced elevation of miR-206-3p) should also be confirmed in vivo using an irradiated mouse brain to correlate the cognitive dysfunction timepoint.</p><p>Antago-miR-206-3p reversed Ir-induced upregulation of miR-206 (in vitro), and prevent reductions in PAK3 and downstream markers. Importantly, it reversed cognitive deficits induced by IR. This data should be supported by in vivo staining for important dendritic markers, including cofillin, p-cofilin, PSD-95, F- and G-actin within the hippocampal and PFC regions.</p><p>Other neuronal and non-neuronal targets of miR-206-3p should be discussed and looked into as a downstream impact of IR-induced functional and physiological impairments in the brain.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89221.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The paper entitled &quot;PAK3 downregulation induces cognitive 1 impairment following cranial irradiation&quot; by Lee et al. aimed at investigating the functional impact of cranial irradiation in mouse and propose PAK3 as molecular element involved in radiation-induced cognitive decrement. The results provided in this paper are problematic as both the irradiation paradigm (5X2 Gy) as well as the timing of investigation (3 to 8 days post-IR) are completely irrelevant to investigate radiation induced neurocognitive impairment. This testifies to the team's lack of knowledge in radiobiology/radiotherapy and the methodology to explore radiation induced neurocognitive damages. It precludes any further relevance of the molecular results.</p><p>Weaknesses:</p><p>First and according to the BED equation a single dose of 10 Gy cannot not be approximated by 5 fractions of 2 Gy, as fractionation is known to decrease normal tissue toxicity. Note that in radiobiology/radio-oncology, the BED stands for &quot;Biologically Effective Dose.&quot; This equation is used to compare the effects of different radiation treatments on biological tissues, taking into account the dose, fractionation, and the overall biological response of the tissue to radiation.</p><p>The BED equation is commonly used to calculate the equivalent dose of a fractionated radiation treatment, which is the dose that would produce the same biological effect as a single, higher dose delivered in a single fraction.</p><p>The general formula for BED is:BED = D * (1 + d / α/β)</p><p>D is the total physical dose of radiation delivered in Grays (Gy)</p><p>d is the dose per fraction in Gy</p><p>α/β is the tissue-specific ratio of the linear (α) and quadratic (β) components of the radiation response. It is measured in Gy and describes how the tissue responds to different fractionation schedules (usually equal to 3 for the normal brain).</p><p>Please refer to radiobiology/radiotherapy textbooks by Hall or Joiner.</p><p>Second, the brain is a late responding organ. GBM patients treated with 60 Gy exhibit progressive and debilitating impairments in memory, attention and executive function several month post-irradiation. In mice, neurocognitive decrements after a single dose of 10 Gy delivered to the whole brain does occur at late time point, usually &gt; 2 months post-exposure. Multiple publications such as the one by Limoli C lab, Rossi S lab, Britten R lab or earlier Fike J lab and Robin M lab support this. Next, 5 fractions of 2 Gy will be more protective than a single dose of 10 Gy and neurocognitive decrements will require at least 5-6 months to occur if they ever occur. In Figure 1, the decrement reported is marginal, the number of animals included (4 to 5 at most?) The number of animals is not specified is too low to draw any significant conclusions. In addition to the timing issue, the strategy described for NOR analysis shows methodological issues with the habituation period being too short and exploration level being very low.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89221.3.sa3</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Haksoo</given-names></name><role specific-use="author">Author</role><aff><institution>Pusan National University</institution><addr-line><named-content content-type="city">Busan</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kang</surname><given-names>Hyunkoo</given-names></name><role specific-use="author">Author</role><aff><institution>Pusan National University</institution><addr-line><named-content content-type="city">Busan</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Moon</surname><given-names>Changjong</given-names></name><role specific-use="author">Author</role><aff><institution>Chonnam National University</institution><addr-line><named-content content-type="city">Gwangju</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Youn</surname><given-names>BuHyun</given-names></name><role specific-use="author">Author</role><aff><institution>Pusan National University</institution><addr-line><named-content content-type="city">Busan</named-content></addr-line><country>Republic of Korea</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1</bold></p><p>1. IR reduced mature spines (mushroom) but not immature spines (filopodia) in vitro at 14 days post-2 Gy IR. Please check previous reports by C. Limoli and J. Fike groups (in vivo dendritic spine characterization following proton or photon irradiation).</p></disp-quote><p>We appreciate the reviewer's comments. Although IR did not reduce filopodia in the previous study, there are no prior studies using the same time points as ours, 4 days post-2 Gy IR. Additionally, according to other previous studies, PAK3 inhibition led to an increase in filopodia (J Neurosci. 2004 Dec 1;24(48):10816-25), and IR increased thin-type spines and decreased mushroom-type spines at the 7 days after 2 Gy IR (PLoS One. 2012;7(7):e40844). Considering these findings, we believe that the increase in filopodia observed in our study is due to the short-term effects of IR and the consequent PAK3 downregulation. We added the description regarding time point in “Materials and Methods”.</p><p>Page 20, line 439-440; &quot;In the analysis of molecular alterations, cultured neurons were sampled 4 days after irradiation.&quot;</p><disp-quote content-type="editor-comment"><p>2. Does IR (2 Gy or 5 x 2 Gy) affect the viability in vitro? This could be linked with reduced dendritic structure and F/G-actin ratios.</p></disp-quote><p>As the reviewer mentioned, we evaluated neuronal viability following 2 Gy IR exposure. Consequently, approximately 80% of the cells survived after the IR exposure (Fig. 4A). Although we agree that cognitive abilities may decrease due to the neuron death after IR, we identified that PAK3 overexpression restores the F/G-actin ratio in surviving neurons after IR, suggesting the IR-induced alterations at least in neuronal plasticity are mainly regulated by PAK3 rather than IR itself. Additionally, neurons that survive after IR maintain similar levels of NeuN, a mature neuron marker (Fig. S5A). We added the description regarding additional experiments in “Results”.</p><p>Page 10, line 206-209; &quot;IR decreased neuronal viability in human differentiated neurons, with approximately 80% survival (Fig 4A). However, IR did not alter the mature neuronal marker, NeuN (Fig S5A). These results indicate that IR-induced disruption of PAK3 signaling occurs in surviving neurons following irradiation. Consistent with previous murine neuron data, IR reduced the F/G-actin ratio (Fig. 4B).&quot;</p><disp-quote content-type="editor-comment"><p>3. The authors state, &quot;Overall, these results indicated that IR could induce cognitive impairment by disrupting dendritic spine maturation.&quot; Dendritic spine damage may not be the only factor contributing to cognitive dysfunction (neural circuit function, neuroinflammation, astrogliosis, etc., needs to be discussed).</p></disp-quote><p>We agree with the reviewer's comment that dendritic spine damage may not be the only factor contributing to cognitive impairment. Since our study has only confirmed the effects on dendritic spines as part of the complex impact of radiation, we added the description of the necessity for further research on various factors related to IR-induced cognitive dysfunction in “Discussion”.</p><p>Page 15, line 317-324; &gt;The dendritic spine is one of the major factors influencing cognitive function. In our study, we observed changes in dendritic spines due to radiation exposure, followed by subsequent cognitive impairment. Additionally, we established that regulating PAK3, which affects dendritic spine maturation, can modulate radiation-induced cognitive dysfunction. However, considering that radiation can impact the entire nervous system and that neural circuit function, neuroinflammation, and astrogliosis can also influence cognitive function (Makale et al., 2017), future studies is needed to investigate the mechanisms of factors beyond dendritic spine changes caused by radiation.&gt;</p><disp-quote content-type="editor-comment"><p>4. Fig 2 and Suppl Fig S2. The in vivo results should be placed in the manuscript Fig 2 as this would provide relevant physiological information on PAK3 downregulation and reduced dendritic spines and cognition.</p></disp-quote><p>We appreciated the reviewer's comment. As the reviewer mentioned, we rearranged Fig S2C to Fig 2H.</p><p>Page 33, line 825-827; &quot;(H) Left: the protein levels of phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR in frontal cortex and hippocampus. Right: each western blot bands are quantified by ImageJ.&quot;</p><disp-quote content-type="editor-comment"><p>5. miR-206-3p expression was found to be elevated post-IR in the human and mouse neurons in vitro. This was correlated with IR-induced downregulation of PAK3 using an antagonist miR experiment, wherein PAK3, LIMK1, and downstream makers were restored in the irradiated neurons. MiR-206-3p upregulation data should also be confirmed in vivo using an irradiated mouse brain to correlate the cognitive dysfunction timepoint.</p></disp-quote><p>We observed IR-induced miR-206-3p upregulation (Fig 6D) and consequent PAK3 downregulation (Fig 6G) in vivo at 4 days after IR. Considering that the antagomiR significantly restores cognitive dysfunction (Fig 6E) at 1-3 days after IR, we suppose the expression of miR-206-3p would be consistently increased by IR, suppressing the PAK3 signaling pathway and leading to cognitive dysfunction.</p><p>Page 33, line 825-827; &quot;(H) Left: the protein levels of phosphorylated LIMK1, LIMK1, phosphorylated cofilin, and cofilin after IR in frontal cortex and hippocampus. Right: each western blot bands are quantified by ImageJ.&quot;</p><disp-quote content-type="editor-comment"><p>6. Fig 5 shows that in vivo administration of antago-miR-206 reversed IR-induced upregulation of miR-206, reductions in PAK3 and downstream markers, and, importantly, reversed cognitive deficits induced by IR. This data should be supported by in vivo staining for important dendritic markers, including cofillin/p-cofilin, PSD-95, F- and G-actin within the hippocampal and PFC regions.</p></disp-quote><p>We appreciated the reviewer's comment. Based on previous studies on intranasal administration, the substance is delivered to the PFC and hippocampus through the olfactory pathway in both humans and mice (Exp Neurobiol. 2020 Dec 31;29(6):453-469, Stem Cells. 2021 Dec;39(12):1589-1600). Even though we did not show direct evidence that antagomiR-206 is delivered to both regions, we confirmed its actual delivery to the brain using Cy5 fluorescence and examined PAK3 signaling (Fig. 6G) and the F/G-actin ratio (Fig. 6H) in both regions. To show the reliability of the tissue separation, we added a detailed description of the tissue separation method in “Materials and Methods”.</p><p>Page 19, line 410-423; &quot;Dissection of prefrontal cortex and hippocampus. The dissection of mouse brain regions was performed following a previous study (Spijker, 2011). First, to obtain the hippocampal region, we gently held the brain and opened the forceps, slowly separating the cortical halves. Once an opening had been created along the midline for approximately 60%, we directed the forceps (in the closed position) counterclockwise by 30–40° to expose the left cortex from the hippocampus, repeatedly opening the forceps as necessary. We then repeated the same procedure for the right cortex by pointing the forceps in a 30–40° clockwise direction until the upper part of the hippocampus became visible. At the most caudal part of the hippocampus/cortex boundary, we moved the small forceps through the cortex and used them to separate the hippocampus from the fornix. After removing the hippocampus, we used the large forceps to fold the cortex back into its original position. Subsequently, we placed the brain with the dorsal side and cut coronal sections to reveal the prefrontal cortex and striatum at different levels. Using a sharp razor blade, we made the first cut to remove the olfactory bulb and cut the section containing the prefrontal cortex.&quot;</p><disp-quote content-type="editor-comment"><p>7. Does this change in the F/G actin ratios, Cofillin, and/or p-Cofillin impact any particular neuronal subtypes, including excitatory, inhibitory or any particular layers of major neurons? This point can't be appreciated from the WB data.</p></disp-quote><p>The excitatory and inhibitory neurons do play crucial roles in cognitive function. In terms of response to radiation, excitatory neurons are more likely to be responsive. A previous study showed that spike firing and excitatory synaptic input were reduced by cranial irradiation, while inhibitory input was increased (Neural Regen Res. 2022 Oct;17(10):2253-2259). Additionally, PSD-95 is localized to dense specialized regions within the dendritic spines of excitatory synapses and is associated with synaptic plasticity (Neuron. 2001 Aug 2;31(2):289-303). Indeed, IR decreases the mRNA level of PSD-95 in differentiated human neurons (Fig S5A). Considering the previous research and our data, IR-induced PAK3 downregulation may occur primarily in excitatory neurons.</p><disp-quote content-type="editor-comment"><p>8. Discussion: &quot;In this study, we investigated the effect of cranial irradiation on cognitive function and the underlying mechanisms in a mouse model.&quot; Please change this statement to &quot;....underlying neuronal mechanisms using in vivo and in vitro models.&quot;</p></disp-quote><p>We appreciate the reviewer’s comment. We replaced ‘mechanisms in a mouse model’ with ‘neuronal mechanisms using in vivo and in vitro models.’ in the manuscript.</p><p>Page 14, line 283; &quot;In this study, we investigated the effect of cranial irradiation on cognitive function and the underlying neuronal mechanisms using in vivo and in vitro models.&quot;</p><disp-quote content-type="editor-comment"><p>9. Discussion: &quot;Furthermore, our study identifies a potential mechanism underlying the cognitive impairment associated with cranial irradiation, which downregulates PAK3 expression.&quot; This statement should be supported by the in vivo immunofluorescence data for the synaptic markers, including cofilin, p-cofillin, PSD-95, and F/G-actin staining.</p></disp-quote><p>Even though we did not show the in vivo immunofluorescence data for the synaptic markers, we examined PAK3 signaling (Fig. 6G) and the F/G-actin ratio (Fig. 6H) in the hippocampal and PFC regions. Additionally, according to The Allen Mouse Brain Atlas, PAK3 is mainly expressed in the PFC and hippocampus regions (Fig S2A), suggesting that IR-induced PAK3 downregulation in both regions may have a significant impact on the cognitive impairment. Considering these data, we strongly believe that cranial irradiation downregulates PAK3 levels in the PFC and hippocampus, thus inducing cognitive impairment.</p><disp-quote content-type="editor-comment"><p>10. miR modulate function by affecting multiple targets. The other potential neuronal and non-neuronal targets for miR-206-3p were not discussed. This possibility should be confirmed using relevant markers.</p></disp-quote><p>According to the reviewer’s comment, we performed real-time PCR to examine whether miR-206-3p affects the expressions of neuronal and non-neuronal markers (Fig S5A and S5B). As a result, the post-synaptic marker, PSD-95, was reduced by miR-206-3p treatment. However, a mature neuronal marker (NeuN) and non-neuronal markers (GFAP and IBA-1) did not change upon miR-206-3p treatment. We added the related description in “Results”.</p><p>Page 12, line 240-243; &quot;Additionally, the post-synaptic marker, PSD-95, was decreased by miR-206-3p treatment. However, a mature neuronal marker (NeuN) and non-neuronal markers (GFAP and IBA-1) were not alterd upon miR-206-3p treatment (Fig. S5A and S5B).&quot;</p><disp-quote content-type="editor-comment"><p>10. Irradiation procedure: Please confirm that sham (0 Gy)-irradiated mice were also anesthetized for a similar procedure carried out for the 2 Gy or fractionated irradiation.</p></disp-quote><p>According to the reviewer's comment, we added a description of sham (0 Gy)-irradiated mice in “Materials and Methods”.</p><p>Page 17, line 359-360; &quot;All mice, including those in the sham (0 Gy) group, were anesthetized with an intraperitoneal (i.p.) injection of zoletil (5 mg/10 g) daily for five days.&quot;</p><disp-quote content-type="editor-comment"><p>12. 24 mL volume (antagomir treatment) via intra-nasal delivery is a rather unusually high volume. Please clarify if such a procedure was approved by the regulatory committee and if 24 mL volume led to any hemodilution.</p></disp-quote><p>We appreciate the reviewer's comment. We referred to the protocol of intranasal administration from a previous study (Mol Ther. 2021 Dec 1;29(12):3465-3483), and made an error in specifying the miRNA unit. We corrected it from mL to μL.</p><p>Page 19, line 399-402; &quot;According to the manufacturer’s instructions and previous study (Zhou et al., 2021), 40 nmol of antagomiR-206-3p (sequence: 5’-CCACACACUUCCUUACAUUCCA -3’) or antagomiR-NC (the antagomiR negative control, its antisense chain sequence: 5’-UCUACUCUUUCUAGGAGGUUGUGA-3’) was dissolved in 1 mL of RNase-free water.&quot;</p><p>Page 19, line 402-403; &quot;A total of 24 μL of the solution (1 nmol per one mouse) was instilled with a pipette, alternately into the left and right nostrils (1 μL/time), with an interval of 3–5 min.&quot;</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2</bold></p><p>1. To show the relevance of PAK3 in Radiation-induced neurocognitive decrements, I suggest using 10 Gy WBI, group of 15-16 animals and long-term follow up &gt;2 months post-RT.</p></disp-quote><p>We appreciate the reviewer's comment. Biologically Effective Dose (BED) represents the most accurate quantitative prediction of biological effects of radiation. However, our study aimed to analyze the mechanisms underlying cognitive dysfunction induced not by a total dose of 10 Gy but rather by repeating 2 Gy fractions, which is used in clinical practice such as prophylactic cranial irradiation. In this regard, the administration of 2 Gy fractions holds significant relevance in our research.</p><p>In statistical analysis, a larger sample size tends to be more accurate. However, we determined the sample size based on ethical considerations in animal research, taking into account the parameter (Effect size: 1.2 / alpha value: 0.05 / Group: 3 groups), resulting in a total sample size of 15, five mice per group (G Power 3.1 software). Despite the relatively small sample size, radiation exposure significantly reduced PAK3 expression with marginal variance, thereby inducing cognitive impairment.</p><p>As the reviewer mentioned, the long-term effect (&gt;2 months) of WBI may show more severe cognitive impairment, considering results from the previous studies. Nevertheless, previous research has revealed a correlation between mouse age and human age, suggesting that 2 months in mice is roughly equivalent to 5 years in humans (Life Sci. 2020 Feb 1;242:117242). Due to the substantial difference in biological time between humans and mice, 2 months in mice might be an excessive long-term period. Additionally, our study aims to investigate short-term changes rather than long-term effects. It is clear that IR-induced PAK3 downregulation induces cognitive impairment at least in the short-term period, and we believe that our findings may contribute to preventing serious neuronal dysfunction as the long-term side effects of PCI.</p></body></sub-article></article>